_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,e1,e2,expertdecision,relation,sent_id,sentence,term1,term2
497505641,7/2/2014 23:53:40,,1313494351,7/2/2014 23:53:29,prodege,1,7061586,AUS,02,Toongabbie,114.76.177.0,[TREATS],[TREATS],treatment,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 00:18:34,,1313506261,7/3/2014 00:17:50,clixsense,1,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM],[SYMPTOM],after the first epileptic seizure,N/A,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 00:36:43,,1313514525,7/3/2014 00:36:29,neodev,1,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],after,N/A,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 01:03:06,,1313528620,7/3/2014 01:02:41,clixsense,1,10428985,GBR,M3,South Petherton,86.186.150.111,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment decreases,N/A,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 03:56:33,,1313633162,7/3/2014 03:56:03,zoombucks,1,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],epileptic,N/A,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 04:05:32,,1313637572,7/3/2014 04:04:34,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.161,[SYMPTOM],[SYMPTOM],treatment epileptic seizure number of,N/A,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 04:24:14,,1313644907,7/3/2014 04:23:34,rewardsspot,1,17763704,USA,VA,Manassas,198.7.62.204,[PREVENTS],[PREVENTS],EPILEPSY SEIZURES,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 04:43:22,,1313651965,7/3/2014 04:43:00,neodev,1,15848372,AUS,02,Jannali,27.96.208.89,[SYMPTOM],[SYMPTOM],of,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 05:00:46,,1313660452,7/3/2014 05:00:20,rewardsspot,1,24482174,GBR,H9,London,46.23.68.180,[CAUSES],[CAUSES],EPILEPSY SEIZURES,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 05:08:17,,1313664072,7/3/2014 05:07:55,tremorgames,1,19721342,CAN,ON,Ottawa,99.246.56.98,[CAUSES],[CAUSES],epileptic seizure,N/A,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 07:39:00,,1313737491,7/3/2014 07:38:48,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",EPILEPSY SEIZURES,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 08:00:31,,1313759503,7/3/2014 07:58:01,neodev,1,18755947,GBR,H2,Accrington,80.47.187.155,[MANIFESTATION],[MANIFESTATION],epileptic seizure,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 08:37:20,,1313786402,7/3/2014 08:36:29,prodege,1,15439740,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],decreases effectively the number,n/a,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 09:09:44,,1313820743,7/3/2014 09:09:03,prodege,1,18240009,GBR,H9,London,159.92.106.183,[SYMPTOM],[SYMPTOM],decreases,na,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505641,7/3/2014 11:18:07,,1313916108,7/3/2014 11:17:13,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],EPILEPSY SEIZURES,manifestation,96,17,104,25,-1,RO-has_definitional_manifestation,904946,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY
497505642,7/2/2014 23:54:23,,1313494719,7/2/2014 23:54:04,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],occurred,n/a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 00:10:47,,1313502583,7/3/2014 00:10:27,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[MANIFESTATION] [CONTRAINDICATES],"[MANIFESTATION]
[CONTRAINDICATES]",occurred in,N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 01:06:19,,1313530256,7/3/2014 01:05:21,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[MANIFESTATION],[MANIFESTATION],occurred,N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 03:55:28,,1313632499,7/3/2014 03:54:54,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",AIDS HAEMOPHILIA B,n/a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 04:06:25,,1313637980,7/3/2014 04:06:10,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurred,N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 04:49:06,,1313654550,7/3/2014 04:48:47,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],occurred in,N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 04:57:00,,1313658386,7/3/2014 04:55:16,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",AIDS HAEMOPHILIA B (CHRISTMAS DISEASE),n/a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 04:57:08,,1313658460,7/3/2014 04:56:29,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],HAEMOPHILIA B (CHRISTMAS DISEASE),is a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 05:16:52,,1313669055,7/3/2014 05:16:31,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],HAEMOPHILIA B,N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 07:32:56,,1313733144,7/3/2014 07:32:44,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AIDS HAEMOPHILIA (CHRISTMAS DISEASE),n/a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 07:56:35,,1313754833,7/3/2014 07:55:41,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[IS_A],[IS_A],HAEMOPHILIA B (CHRISTMAS DISEASE),n/a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 09:08:00,,1313818758,7/3/2014 09:07:39,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],HAEMOPHILIA B (CHRISTMAS DISEASE),na,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 14:36:45,,1314008076,7/3/2014 14:36:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],(CHRISTMAS DISEASE),N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 14:43:52,,1314012916,7/3/2014 14:43:45,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],HAEMOPHILIA (CHRISTMAS,n/a,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505642,7/3/2014 15:03:16,,1314030334,7/3/2014 15:03:03,fepcrowdflower,1,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(CHRISTMAS DISEASE),N/A,37,52,50,69,-1,RO-has_manifestation,906444,A few cases of AIDS have occurred in HAEMOPHILIA B (CHRISTMAS DISEASE) patients,HAEMOPHILIA B,CHRISTMAS DISEASE
497505643,7/3/2014 00:02:27,,1313498495,7/3/2014 00:02:12,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],combined,n/a,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 00:10:09,,1313502148,7/3/2014 00:09:32,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combined,N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 00:21:50,,1313507882,7/3/2014 00:21:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combined with,N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 02:21:47,,1313578075,7/3/2014 02:20:34,tremorgames,1,25257192,CAN,ON,North York,207.188.64.245,[OTHER],[OTHER],"CONGENITAL ANIRIDIA combined with CATARACT,",N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 03:46:29,,1313627097,7/3/2014 03:46:12,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combined with,N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 04:16:10,,1313642301,7/3/2014 04:15:29,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],"CONGENITAL ANIRIDIA CATARACT,",n/a,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 04:42:35,,1313651603,7/3/2014 04:41:55,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]","CONGENITAL ANIRIDIA CATARACT,",n/a,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 04:54:12,,1313656952,7/3/2014 04:53:27,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combined with,n/a,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 05:26:50,,1313675607,7/3/2014 05:26:31,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[PART_OF],[PART_OF],combined,N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 07:40:44,,1313739001,7/3/2014 07:39:52,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CONGENITAL ANIRIDIA combined with CATARACT,",associated with,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 09:11:05,,1313822413,7/3/2014 09:10:41,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],combined with,na,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 09:57:38,,1313855759,7/3/2014 09:56:51,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],we have implanted,N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 10:47:54,,1313888304,7/3/2014 10:47:38,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CONGENITAL ANIRIDIA CATARACT,",n/a,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 14:41:19,,1314011146,7/3/2014 14:41:09,instagc,1.0,27753923,GBR,"","",92.40.75.232,[MANIFESTATION],[MANIFESTATION],implanted this,n/a,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505643,7/3/2014 15:14:46,,1314039030,7/3/2014 15:14:35,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combined with,N/A,98,64,106,83,-1,RO-has_manifestation,906016,"Since June 1991, we have implanted this IOL into five eyes with CONGENITAL ANIRIDIA combined with CATARACT, and into eight eyes with traumatic aniridia combined with cataract or aphakia",CATARACT,CONGENITAL ANIRIDIA
497505644,7/2/2014 23:58:26,,1313496608,7/2/2014 23:58:12,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],developed,n/a,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 00:39:23,,1313515555,7/3/2014 00:39:09,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM],[SYMPTOM],developed,N/A,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 03:28:36,,1313616353,7/3/2014 03:28:05,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[CAUSES],[CAUSES],"BLOOM SYNDROME, WILMS TUMOR",n/a,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 03:28:39,,1313616371,7/3/2014 03:26:46,superrewards,1,23067591,USA,VA,Earlysville,71.48.142.94,[OTHER] [MANIFESTATION],"[MANIFESTATION]
[OTHER]","boy with BLOOM SYNDROME, developed WILMS TUMOR",Na,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 03:51:12,,1313629865,7/3/2014 03:50:50,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CAUSES],[CAUSES],"BLOOM SYNDROME, WILMS TUMOR",n/a,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 04:04:38,,1313637200,7/3/2014 04:04:25,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[MANIFESTATION],[MANIFESTATION],developed,N/A,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 04:07:45,,1313638574,7/3/2014 04:05:37,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",developed,N/A,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 04:47:18,,1313653785,7/3/2014 04:46:58,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],developed,N/A,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 05:28:50,,1313676664,7/3/2014 05:28:36,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[MANIFESTATION],[MANIFESTATION],developed,N/A,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 07:40:33,,1313738841,7/3/2014 07:40:21,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]","BLOOM SYNDROME, WILMS TUMOR",n/a,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 07:53:48,,1313751333,7/3/2014 07:53:28,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[MANIFESTATION],[MANIFESTATION],"with BLOOM SYNDROME, developed a WILMS TUMOR",n/a,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 08:22:33,,1313777337,7/3/2014 08:20:51,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],developed,n/a,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 09:04:21,,1313814643,7/3/2014 09:03:58,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[ASSOCIATED_WITH],[ASSOCIATED_WITH],developed,na,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 09:40:49,,1313845056,7/3/2014 09:40:25,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],developed,N/A,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505644,7/3/2014 11:17:12,,1313915131,7/3/2014 11:16:37,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],"BLOOM SYNDROME, WILMS TUMOR",manifestation,71,43,82,57,1,RO-disease_may_have_finding,902545,"CASE REPORT: Morgan, a 4-year-old boy with BLOOM SYNDROME, developed a WILMS TUMOR",WILMS TUMOR,BLOOM SYNDROME
497505645,7/3/2014 00:08:50,,1313501449,7/3/2014 00:08:06,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH] [PREVENTS],"[PREVENTS]
[ASSOCIATED_WITH]",decreased,n/a,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 00:37:17,,1313514770,7/3/2014 00:37:08,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 01:11:07,,1313533997,7/3/2014 01:10:34,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]","decreased renal function,",N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 03:42:56,,1313625127,7/3/2014 03:42:12,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA,",n/a,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 03:51:10,,1313629854,7/3/2014 03:50:51,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],pentad,N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 04:10:01,,1313639640,7/3/2014 04:09:19,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA,",N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 04:45:33,,1313652966,7/3/2014 04:44:48,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA,",n/a,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 04:57:04,,1313658426,7/3/2014 04:56:43,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 05:08:46,,1313664351,7/3/2014 05:08:18,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],of,N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 08:16:51,,1313773919,7/3/2014 08:16:32,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 09:16:15,,1313828185,7/3/2014 09:16:02,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no direct relation in sentence,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 10:50:44,,1313890260,7/3/2014 10:50:32,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA,",n/a,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 11:19:03,,1313917135,7/3/2014 11:18:08,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PART_OF],[PART_OF],"multi-systemic disorder characterized THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA,",part of,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 14:30:23,,1314003844,7/3/2014 14:29:57,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,N/A,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505645,7/3/2014 14:38:31,,1314009231,7/3/2014 14:38:19,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],clinical pentad,n/a,70,88,86,121,-1,RO-has_manifestation,906020,"It is a multi-systemic disorder characterized by a clinical pentad of THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC ANEMIA, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",THROMBOCYTOPENIA,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505646,7/2/2014 23:59:05,,1313496860,7/2/2014 23:58:48,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",diagnosis associated,n/a,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 00:01:48,,1313498153,7/3/2014 00:01:36,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",associated with,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 01:04:46,,1313529307,7/3/2014 01:03:40,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]",increased diagnosis associated,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 01:22:06,,1313541943,7/3/2014 01:21:28,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM],[SYMPTOM],allowing the diagnosis of when,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 03:35:09,,1313620479,7/3/2014 03:33:55,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MIGRAINE NAUSEA,",n/a,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 03:45:02,,1313626268,7/3/2014 03:44:17,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MIGRAINE NAUSEA,",n/a,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 03:47:15,,1313627652,7/3/2014 03:46:53,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],diagnosis,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 04:10:50,,1313640039,7/3/2014 04:10:10,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",diagnosis of headache is associated,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 04:56:41,,1313658251,7/3/2014 04:56:18,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 04:57:57,,1313658936,7/3/2014 04:57:09,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MIGRAINE associated NAUSEA,",associated with,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 05:10:55,,1313665534,7/3/2014 05:10:39,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 07:39:40,,1313738061,7/3/2014 07:39:30,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MIGRAINE NAUSEA,",n/a,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 08:16:30,,1313773746,7/3/2014 08:14:26,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 14:35:37,,1314007391,7/3/2014 14:35:13,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],the criteria of,n/a,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505646,7/3/2014 15:24:33,,1314047147,7/3/2014 15:24:19,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,195,146,201,154,-1,RO-has_manifestation,906416,"The sensitivity of the IHS criteria for migraine could be increased by reducing the minimum duration of migraine and by allowing the diagnosis of MIGRAINE when severe headache is associated with NAUSEA, even though the criteria of location, quality, and aggravation by physical activity are not fulfilled",NAUSEA,MIGRAINE
497505647,7/3/2014 00:11:04,,1313502810,7/3/2014 00:10:50,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 00:39:52,,1313515743,7/3/2014 00:39:43,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 03:56:01,,1313632815,7/3/2014 03:55:49,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 03:57:30,,1313633664,7/3/2014 03:56:54,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Allergic diseases such as and,N/A,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 04:18:17,,1313643008,7/3/2014 04:17:41,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ALLERGIC RHINITIS ATOPIC DERMATITIS,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 04:49:22,,1313654655,7/3/2014 04:49:08,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 04:52:01,,1313655876,7/3/2014 04:51:09,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ALLERGIC RHINITIS ATOPIC DERMATITIS,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 05:05:29,,1313662678,7/3/2014 05:05:04,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 05:17:37,,1313669526,7/3/2014 05:16:27,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Allergic diseases such as,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 07:31:07,,1313732184,7/3/2014 07:30:44,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ALLERGIC RHINITIS ATOPIC DERMATITIS,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 08:11:19,,1313770828,7/3/2014 08:09:30,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 09:28:58,,1313837447,7/3/2014 09:28:07,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],diseases such as,N/A,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 14:34:16,,1314006465,7/3/2014 14:33:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[OTHER],[OTHER],Allergic diseases such as,Both allergic diseases.,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 14:39:56,,1314010155,7/3/2014 14:39:45,instagc,1.0,27753923,GBR,"","",92.40.75.232,[TREATS],[TREATS],RHINITIS ATOPIC,n/a,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505647,7/3/2014 15:15:42,,1314039761,7/3/2014 15:15:31,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,43,65,60,82,-1,RO-has_manifestation,906317,"Allergic diseases such as allergic asthma, ALLERGIC RHINITIS and ATOPIC DERMATITIS are characterized by a complex interaction of different cell types and mediators",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505648,7/3/2014 00:14:30,,1313504420,7/3/2014 00:14:15,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 00:46:29,,1313519040,7/3/2014 00:46:19,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 04:03:48,,1313636828,7/3/2014 04:03:26,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],-,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 04:26:52,,1313645834,7/3/2014 04:26:15,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],DISEASE NAME AND SYNONYMS: Syndromic diarrhea CIRRHOSIS NEONATAL HEMOCHROMATOSIS,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 04:37:00,,1313649211,7/3/2014 04:35:43,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PART_OF],[PART_OF],DISEASE NAME AND SYNONYMS: Syndromic CIRRHOSIS NEONATAL HEMOCHROMATOSIS phenotypic,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 04:55:08,,1313657438,7/3/2014 04:54:36,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[PART_OF],[PART_OF],-,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 05:24:40,,1313674142,7/3/2014 05:24:17,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[MANIFESTATION],[MANIFESTATION],CIRRHOSIS NEONATAL HEMOCHROMATOSIS,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 07:34:05,,1313733793,7/3/2014 07:33:48,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",DISEASE NAME AND SYNONYMS: CIRRHOSIS NEONATAL HEMOCHROMATOSIS,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 07:51:38,,1313748937,7/3/2014 07:51:04,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[IS_A],[IS_A],SYNONYMS:,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 08:28:45,,1313781189,7/3/2014 08:28:08,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[OTHER],[OTHER],-,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 09:06:12,,1313816768,7/3/2014 09:05:44,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 09:31:55,,1313839450,7/3/2014 09:31:00,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 14:25:47,,1314000919,7/3/2014 14:24:40,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],SYNONYMS:,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 14:35:00,,1314006912,7/3/2014 14:34:48,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],HEMOCHROMATOSIS phenotype intractable,n/a,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505648,7/3/2014 15:24:07,,1314046697,7/3/2014 15:23:52,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SYNONYMS:,N/A,186,198,195,222,-1,RO-has_manifestation,906105,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS
497505649,7/2/2014 23:58:10,,1313496471,7/2/2014 23:57:50,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],contributing,n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 00:21:24,,1313507687,7/3/2014 00:20:33,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM],[SYMPTOM],may help to elucidate the classification of,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 00:47:27,,1313519609,7/3/2014 00:47:16,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM],[SYMPTOM],elucidate,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 03:46:46,,1313627275,7/3/2014 03:45:59,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PREVENTS],[PREVENTS],HAIR PULLING TRICHOTILLOMANIA,n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 03:51:32,,1313630117,7/3/2014 03:51:11,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],help to elucidate,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 05:07:08,,1313663471,7/3/2014 05:06:28,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],elucidate,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 05:08:12,,1313664040,7/3/2014 05:07:41,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PREVENTS],[PREVENTS],HAIR PULLING TRICHOTILLOMANIA (TTM),n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 05:47:06,,1313686183,7/3/2014 05:43:59,prodege,1,20472192,CAN,BC,Richmond,66.183.145.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],elucidate,n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 06:15:13,,1313701137,7/3/2014 06:13:53,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],HAIR PULLING classification TRICHOTILLOMANIA impulse control disorder,symptom,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 08:08:07,,1313768974,7/3/2014 08:07:33,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[PREVENTS],[PREVENTS],elucidate,n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 09:40:23,,1313844839,7/3/2014 09:39:06,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],classification,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 10:45:45,,1313886970,7/3/2014 10:45:18,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HAIR PULLING TRICHOTILLOMANIA,n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 14:39:44,,1314010042,7/3/2014 14:39:36,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],sensory states contributing,n/a,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 15:17:31,,1314041202,7/3/2014 15:17:15,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[PREVENTS],[PREVENTS],maintenance of help elucidate,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505649,7/3/2014 16:11:11,,1314086325,7/3/2014 16:10:18,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[MANIFESTATION],[MANIFESTATION],may help to elucidate the classification of,N/A,99,156,111,172,-1,RO-has_manifestation,906386,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA
497505650,7/2/2014 23:53:17,,1313494129,7/2/2014 23:52:46,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 00:39:41,,1313515680,7/3/2014 00:39:34,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 01:20:58,,1313541162,7/3/2014 01:19:51,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],was consistent with,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 03:42:05,,1313624580,7/3/2014 03:41:13,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CAUSES],[CAUSES],EMPERIPOLESIS ROSAI-DORFMAN DISEASE,n/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 03:58:08,,1313633991,7/3/2014 03:57:41,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],consistent with,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 05:06:54,,1313663371,7/3/2014 05:06:21,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PART_OF],[PART_OF],EMPERIPOLESIS ROSAI-DORFMAN DISEASE,n/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 05:09:06,,1313664460,7/3/2014 05:08:47,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 06:02:40,,1313693844,7/3/2014 06:01:35,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",EMPERIPOLESIS consistent with ROSAI-DORFMAN DISEASE,symptom and / or manifestation,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 09:45:21,,1313848104,7/3/2014 09:44:37,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Pathology showed,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 10:46:26,,1313887414,7/3/2014 10:46:00,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EMPERIPOLESIS ROSAI-DORFMAN DISEASE,n/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 14:34:47,,1314006785,7/3/2014 14:34:31,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],Pathology showed inflammatory,n/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 15:15:57,,1314039916,7/3/2014 15:15:43,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],positive stain,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 16:13:08,,1314087990,7/3/2014 16:12:54,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[SYMPTOM],[SYMPTOM],consistent with,N/A,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 16:25:14,,1314098418,7/3/2014 16:23:51,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[SYMPTOM],[SYMPTOM],was consistent with,n/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505650,7/3/2014 16:33:58,,1314105860,7/3/2014 16:33:20,neodev,1.0,18517457,GBR,"","",86.29.55.201,[SYMPTOM],[SYMPTOM],"in the absence of an infectious agent,",N/a,80,140,93,161,1,RO-disease_has_finding,901928,"Pathology showed inflammatory infiltrate in the absence of an infectious agent, EMPERIPOLESIS and a positive S100 stain was consistent with ROSAI-DORFMAN DISEASE",EMPERIPOLESIS,ROSAI-DORFMAN DISEASE
497505651,7/2/2014 23:53:21,,1313494173,7/2/2014 23:53:13,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/2/2014 23:53:28,,1313494236,7/2/2014 23:53:18,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[MANIFESTATION],[MANIFESTATION],manifested,n/a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 03:31:42,,1313618237,7/3/2014 03:30:37,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MIGRAINE HEADACHE,n/a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 03:43:54,,1313625651,7/3/2014 03:42:59,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[MANIFESTATION],[MANIFESTATION],MIGRAINE HEADACHE,n/a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 03:55:48,,1313632676,7/3/2014 03:55:28,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],and,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 04:09:15,,1313639245,7/3/2014 04:08:08,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH] [SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]
[ASSOCIATED_WITH]",other cases of,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 04:45:53,,1313653165,7/3/2014 04:43:23,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 05:03:34,,1313661772,7/3/2014 05:01:48,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other cases of HEADACHE,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 05:13:36,,1313667058,7/3/2014 05:13:07,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[IS_A],[IS_A],cases of,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 07:41:36,,1313739777,7/3/2014 07:40:46,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],attack MIGRAINE other cases HEADACHE,is a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 07:43:04,,1313741073,7/3/2014 07:42:52,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",MIGRAINE HEADACHE,n/a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 08:36:26,,1313785819,7/3/2014 08:35:20,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treated during an attack other cases,n/a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 09:29:55,,1313838068,7/3/2014 09:29:00,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[PREVENTS],[PREVENTS],relief,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 14:28:47,,1314002748,7/3/2014 14:28:27,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],other cases of,N/A,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505651,7/3/2014 14:39:34,,1314009915,7/3/2014 14:39:25,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],complete relief in,n/a,148,89,156,97,-1,RO-has_definitional_manifestation,904938,The effect was manifested in complete relief in six patients treated during an attack of MIGRAINE and in a relatively high number of other cases of HEADACHE with relief of pain,HEADACHE,MIGRAINE
497505652,7/2/2014 23:52:35,,1313493682,7/2/2014 23:52:25,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 00:12:39,,1313503622,7/3/2014 00:11:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],five patients with 1 with,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 00:15:36,,1313504914,7/3/2014 00:15:09,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],investigated,n/a,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 01:44:05,,1313555955,7/3/2014 01:43:07,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[OTHER] [ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[OTHER]",platelet abnormalities,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 03:37:02,,1313621585,7/3/2014 03:36:20,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SPLENOMEGALY MYELOMONOCYTIC LEUKEMIA,n/a,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 03:39:02,,1313622718,7/3/2014 03:38:08,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PART_OF],[PART_OF],SPLENOMEGALY MYELOMONOCYTIC LEUKEMIA,n/a,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 04:04:05,,1313636958,7/3/2014 04:03:50,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 05:05:23,,1313662634,7/3/2014 05:03:36,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[OTHER],[OTHER],platelet abnormalities,n?A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 05:10:15,,1313665114,7/3/2014 05:09:07,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],and,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 09:16:01,,1313827979,7/3/2014 09:15:33,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,na,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 09:54:16,,1313853905,7/3/2014 09:53:42,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],investigated,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 10:43:47,,1313885700,7/3/2014 10:43:36,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SPLENOMEGALY CHRONIC MYELOMONOCYTIC LEUKEMIA,n/a,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 14:42:56,,1314012272,7/3/2014 14:42:48,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],and platelet,n/a,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 15:23:08,,1314045890,7/3/2014 15:22:55,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505652,7/3/2014 16:14:14,,1314088832,7/3/2014 16:13:31,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[SYMPTOM],[SYMPTOM],with and,N/A,234,322,246,353,1,RO-disease_may_have_finding,902638,"We investigated platelet function, platelet secretion, and platelet morphometry before and one week after splenectomy in seven patients with normal platelet production and normal spleen size (Hodgkin's disease) and five patients with SPLENOMEGALY and platelet abnormalities (4 with myeloproliferative disorders and 1 with CHRONIC MYELOMONOCYTIC LEUKEMIA",SPLENOMEGALY,CHRONIC MYELOMONOCYTIC LEUKEMIA
497505653,7/3/2014 00:16:22,,1313505308,7/3/2014 00:15:38,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",with and,n/a,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 00:47:36,,1313519666,7/3/2014 00:47:29,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 01:02:05,,1313528131,7/3/2014 01:00:43,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES] [SYMPTOM] [MANIFESTATION],"[CAUSES]
[SYMPTOM]
[MANIFESTATION]",at risk,N/A,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 04:06:39,,1313638080,7/3/2014 04:06:27,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 04:08:48,,1313639020,7/3/2014 04:08:10,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MARFAN SYNDROME AORTIC ROOT DILATATION,n/a,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 04:48:08,,1313654125,7/3/2014 04:47:10,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[NONE],[NONE],n/a,two separate conditions,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 04:58:46,,1313659404,7/3/2014 04:57:58,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MARFAN SYNDROME and AORTIC ROOT DILATATION aortic dissection,associated with,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 05:09:42,,1313664802,7/3/2014 05:08:56,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MARFAN SYNDROME AORTIC ROOT DILATATION,n/a,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 05:23:53,,1313673533,7/3/2014 05:23:41,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 05:43:57,,1313684729,7/3/2014 05:43:07,prodege,1.0,20472192,CAN,BC,Richmond,66.183.145.169,[SYMPTOM],[SYMPTOM],and,n/a,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 08:16:58,,1313774036,7/3/2014 08:16:14,prodege,1.0,21891314,AUS,07,Mornington,203.214.41.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk,N/A,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 09:46:56,,1313849170,7/3/2014 09:46:36,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MARFAN SYNDROME and AORTIC ROOT DILATATION,n.a,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 14:24:38,,1314000131,7/3/2014 14:24:21,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Patients with and,N/A,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 14:40:57,,1314010886,7/3/2014 14:40:48,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SYNDROME AORTIC,n/a,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505653,7/3/2014 15:23:51,,1314046475,7/3/2014 15:23:42,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,separate,34,14,56,29,-1,RO-has_manifestation,906062,Patients with MARFAN SYNDROME and AORTIC ROOT DILATATION are at risk for aortic dissection and are difficult to manage,AORTIC ROOT DILATATION,MARFAN SYNDROME
497505654,7/2/2014 23:52:01,,1313493428,7/2/2014 23:51:29,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[MANIFESTATION],[MANIFESTATION],observed,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/2/2014 23:54:47,,1313494931,7/2/2014 23:54:26,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],and,n/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 01:00:46,,1313527431,7/3/2014 00:59:40,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],in the cortices of the with,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 03:43:10,,1313625247,7/3/2014 03:42:47,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],in,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 03:47:34,,1313627790,7/3/2014 03:46:49,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],BRAINS SENILE DEMENTIA,n/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 04:51:33,,1313655711,7/3/2014 04:51:17,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 05:02:25,,1313661260,7/3/2014 05:01:56,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PART_OF],[PART_OF],BRAINS Alzheimer's disease SENILE DEMENTIA,n/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 05:18:16,,1313669928,7/3/2014 05:18:01,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],with,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 09:49:24,,1313850808,7/3/2014 09:48:33,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],observed by means of a scanning,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 10:45:59,,1313887159,7/3/2014 10:45:49,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],BRAINS SENILE DEMENTIA,n/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 14:37:08,,1314008322,7/3/2014 14:36:58,instagc,1.0,27753923,GBR,"","",92.40.75.232,[TREATS],[TREATS],vessels with amyloid,n/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 15:14:12,,1314038669,7/3/2014 15:13:57,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[LOCATION],[LOCATION],cortices of the BRAINS,N/A,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 16:19:03,,1314092744,7/3/2014 16:16:31,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[LOCATION],[LOCATION],with,dementia is found in the brain,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 16:32:23,,1314104504,7/3/2014 16:31:59,neodev,1.0,18517457,GBR,"","",86.29.55.201,[LOCATION],[LOCATION],in the cortices of the,N/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505654,7/3/2014 17:11:51,,1314134833,7/3/2014 17:10:55,prodege,1.0,14848125,GBR,V2,Glasgow,86.130.194.252,[LOCATION],[LOCATION],plaques in the cortices observed,n/a,80,116,86,131,1,RO-has_finding_site,905206,Blood vessels with amyloid angiopathy and senile plaques in the cortices of the BRAINS with Alzheimer's disease and SENILE DEMENTIA were observed by means of a scanning electron microscope,BRAINS,SENILE DEMENTIA
497505655,7/3/2014 00:04:45,,1313499650,7/3/2014 00:04:21,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[IS_A],[IS_A],is,n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 00:37:56,,1313514994,7/3/2014 00:37:46,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,N/A,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 00:58:53,,1313526367,7/3/2014 00:58:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],conditions such as,N/A,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 03:29:36,,1313616961,7/3/2014 03:28:41,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CYSTIC FIBROSIS, BRONCHIECTASIS",n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 03:40:04,,1313623322,7/3/2014 03:39:12,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[SYMPTOM],[SYMPTOM],"CYSTIC FIBROSIS, BRONCHIECTASIS",N/A,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 03:41:10,,1313624085,7/3/2014 03:40:25,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CYSTIC FIBROSIS, BRONCHIECTASIS",n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 03:50:06,,1313629230,7/3/2014 03:49:49,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 05:01:24,,1313660762,7/3/2014 05:00:24,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"commonly-occurring inflammatory diseases airways, CYSTIC FIBROSIS, BRONCHIECTASIS",associated with,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 05:06:57,,1313663394,7/3/2014 05:05:25,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],conditions such as,n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 05:33:04,,1313678976,7/3/2014 05:32:45,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],conditions such as,N/A,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 07:39:55,,1313738280,7/3/2014 07:39:41,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","CYSTIC FIBROSIS, BRONCHIECTASIS",n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 08:39:55,,1313788311,7/3/2014 08:39:40,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 09:23:39,,1313833838,7/3/2014 09:21:23,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],conditions such as,N/A,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 14:34:30,,1314006598,7/3/2014 14:33:38,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],"diseases airways, neutrophil",n/a,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505655,7/3/2014 15:01:36,,1314029057,7/3/2014 15:01:18,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,l;ist,242,188,256,203,-1,RO-has_manifestation,906126,"In the case of commonly-occurring inflammatory diseases of the airways, the neutrophil is the primary mediator of inflammation in conditions such as chronic obstructive pulmonary disease, CYSTIC FIBROSIS, acute respiratory distress syndrome, BRONCHIECTASIS and non-eosinophilic bronchial asthma",BRONCHIECTASIS,CYSTIC FIBROSIS
497505656,7/2/2014 23:59:15,,1313496911,7/2/2014 23:59:06,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[TREATS],[TREATS],treatment,n/a,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 00:06:28,,1313500486,7/3/2014 00:05:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[NONE],[NONE],N/A,No clear relationship.,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 00:47:04,,1313519382,7/3/2014 00:46:54,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],for,N/A,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 01:02:40,,1313528388,7/3/2014 01:02:06,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[TREATS],[TREATS],"treatment treatment for anaphylaxis,",N/A,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 03:34:49,,1313620276,7/3/2014 03:33:32,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ALLERGIC RHINITIS, ATOPIC DERMATITIS,",n/a,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 03:36:22,,1313621166,7/3/2014 03:35:05,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[CAUSES],[CAUSES],"treatment of ALLERGIC RHINITIS, ATOPIC DERMATITIS,",N/A,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 03:53:12,,1313631129,7/3/2014 03:52:57,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"and,",N/A,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 03:54:30,,1313631908,7/3/2014 03:53:39,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treatment of as adjunctive treatment,N/A,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 03:54:51,,1313632099,7/3/2014 03:54:16,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ALLERGIC RHINITIS, ATOPIC DERMATITIS,",n/a,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 04:50:45,,1313655277,7/3/2014 04:50:26,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"and,",N/A,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 05:16:29,,1313668832,7/3/2014 05:15:51,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[NONE],[NONE],N/A,They are treated by the same drug.,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 06:31:14,,1313711049,7/3/2014 06:30:28,eup_slw,1.0,18329415,USA,PA,Folcroft,64.121.230.236,[NONE],[NONE],n/a,both listed as treatable by antihistamines,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 08:13:07,,1313771820,7/3/2014 08:12:18,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"and,",n/a,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 08:57:50,,1313807155,7/3/2014 08:57:16,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],n/a,have same treatment but not related,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505656,7/3/2014 09:43:03,,1313846540,7/3/2014 09:41:59,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],n/a,no relation,48,119,65,136,-1,RO-has_manifestation,906289,"Antihistamines may be used for the treatment of ALLERGIC RHINITIS, upper respiratory infections, urticaria/angioedema, ATOPIC DERMATITIS, and, rarely, as adjunctive treatment for anaphylaxis, during pregnancy",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505657,7/3/2014 00:11:52,,1313503225,7/3/2014 00:11:43,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,n/a,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 00:46:53,,1313519256,7/3/2014 00:46:42,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurring,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 01:44:55,,1313556528,7/3/2014 01:44:10,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[SYMPTOM] [OTHER],"[SYMPTOM]
[OTHER]",occurring spontaneously on a background,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 03:36:24,,1313621191,7/3/2014 03:35:04,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[CAUSES],[CAUSES],SPLENIC RUPTURE INFECTIOUS MONONUCLEOSIS,n/a,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 04:00:08,,1313635178,7/3/2014 03:59:42,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],background,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 04:05:32,,1313637571,7/3/2014 04:03:59,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],SPLENIC RUPTURE INFECTIOUS MONONUCLEOSIS,n/a,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 04:08:19,,1313638835,7/3/2014 04:07:02,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],SPLENIC RUPTURE occurring spontaneously INFECTIOUS MONONUCLEOSIS index of suspicion,manifestation,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 05:10:38,,1313665351,7/3/2014 05:10:16,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],background of,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 05:15:07,,1313667988,7/3/2014 05:13:25,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[CAUSES],[CAUSES],occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS,n/a,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 07:41:38,,1313739805,7/3/2014 07:40:52,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SPLENIC RUPTURE INFECTIOUS MONONUCLEOSIS,n/a,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 09:15:32,,1313827595,7/3/2014 09:14:47,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[MANIFESTATION],[MANIFESTATION],occurring spontaneously,na,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 09:58:33,,1313856287,7/3/2014 09:58:04,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],which a diagnosis,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 14:24:18,,1313999885,7/3/2014 14:23:54,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",on a background of,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 14:35:49,,1314007494,7/3/2014 14:35:39,instagc,1.0,27753923,GBR,"","",92.40.75.232,[SYMPTOM],[SYMPTOM],in a diagnosis,n/a,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505657,7/3/2014 15:13:56,,1314038419,7/3/2014 15:13:29,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],occurring spontaneously,N/A,43,102,58,126,1,RO-disease_may_have_finding,902557,We describe a case in which a diagnosis of SPLENIC RUPTURE occurring spontaneously on a background of INFECTIOUS MONONUCLEOSIS was made as a result of a high index of suspicion,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
497505658,7/3/2014 00:15:07,,1313504718,7/3/2014 00:14:32,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SYMPTOM] [ASSOCIATED_WITH] [SIDE_EFFECT],"[SYMPTOM]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",with,n/a,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 00:39:06,,1313515439,7/3/2014 00:38:58,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 01:00:42,,1313527418,7/3/2014 00:59:33,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",consistent with,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 03:49:22,,1313628774,7/3/2014 03:48:22,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],PANCYTOPENIA HAEMOPHAGOCYTIC SYNDROME,n/a,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 03:50:50,,1313629611,7/3/2014 03:50:33,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],consistent with,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 04:40:29,,1313650589,7/3/2014 04:39:39,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[SYMPTOM],[SYMPTOM],PANCYTOPENIA HAEMOPHAGOCYTIC SYNDROME,n/a,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 04:42:59,,1313651803,7/3/2014 04:42:30,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[SYMPTOM],[SYMPTOM],consistent,n/a,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 05:13:55,,1313667265,7/3/2014 05:13:37,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 07:33:09,,1313733232,7/3/2014 07:32:57,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PANCYTOPENIA HAEMOPHAGOCYTIC SYNDROME,n/a,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 08:55:07,,1313803771,7/3/2014 08:54:27,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[SYMPTOM],[SYMPTOM],consistent with,n/a,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 09:38:42,,1313843809,7/3/2014 09:38:02,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],PANCYTOPENIA HAEMOPHAGOCYTIC SYNDROME,manifestation,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 14:29:56,,1314003556,7/3/2014 14:29:12,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],features consistent with the,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 14:33:04,,1314005727,7/3/2014 14:32:18,instagc,1.0,27753923,GBR,"","",92.40.75.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],features consistent,I didn't say none.,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 15:23:24,,1314046096,7/3/2014 15:23:09,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],consistent with,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505658,7/3/2014 16:12:10,,1314087137,7/3/2014 16:11:49,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[SYMPTOM],[SYMPTOM],features consistent with,N/A,61,118,73,142,1,RO-disease_may_have_finding,902511,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME
497505659,7/3/2014 00:11:43,,1313503167,7/3/2014 00:11:31,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM],[SYMPTOM],during,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 00:16:50,,1313505480,7/3/2014 00:16:35,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],development,n/a,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 01:21:28,,1313541508,7/3/2014 01:20:59,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],comparable with that seen during the development of,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 04:03:10,,1313636456,7/3/2014 04:02:51,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],with,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 04:19:50,,1313643545,7/3/2014 04:19:13,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CONTRAINDICATES],[CONTRAINDICATES],COLON COLITIS,n/a,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 04:47:42,,1313653941,7/3/2014 04:47:20,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],during the development,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 04:59:23,,1313659725,7/3/2014 04:58:44,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[MANIFESTATION],[MANIFESTATION],damage of the COLON,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 05:05:47,,1313662824,7/3/2014 05:05:16,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[SYMPTOM],[SYMPTOM],COLON COLITIS,n/a,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 05:32:22,,1313678575,7/3/2014 05:31:59,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],during the development,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 07:33:21,,1313733353,7/3/2014 07:33:10,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COLON COLITIS,n/a,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 08:09:28,,1313769792,7/3/2014 08:08:09,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],comparable,n/a,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 09:19:48,,1313831064,7/3/2014 09:16:58,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",could be indirectly involved,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 09:37:04,,1313842771,7/3/2014 09:36:04,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COLON COLITIS,associated with,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 14:41:08,,1314011030,7/3/2014 14:40:59,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],"neuronal, neuroendocrine",n/a,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505659,7/3/2014 15:17:44,,1314041333,7/3/2014 15:17:33,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[LOCATION],[LOCATION],COLON,N/A,198,256,203,263,1,RO-has_finding_site,905254,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS
497505660,7/2/2014 23:52:45,,1313493822,7/2/2014 23:52:37,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(the,N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 00:06:23,,1313500443,7/3/2014 00:06:00,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],(the,n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 01:42:06,,1313554594,7/3/2014 01:41:21,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",(the RADIAL GROWTH PHASE) has been demonstrated,N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 03:32:56,,1313619052,7/3/2014 03:32:07,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[MANIFESTATION],[MANIFESTATION],SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) demonstrated different properties,N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 03:42:27,,1313624803,7/3/2014 03:40:58,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SUPERFICIAL SPREADING MELANOMA RADIAL GROWTH PHASE),n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 03:58:42,,1313634292,7/3/2014 03:58:21,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[PART_OF],[PART_OF],(the RADIAL GROWTH PHASE),N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 04:02:25,,1313636189,7/3/2014 04:01:49,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SUPERFICIAL SPREADING MELANOMA RADIAL GROWTH PHASE),n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 04:49:00,,1313654514,7/3/2014 04:48:09,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[MANIFESTATION],[MANIFESTATION],PHASE),n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 05:07:31,,1313663648,7/3/2014 05:07:08,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],component,N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 07:39:29,,1313737904,7/3/2014 07:39:16,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SUPERFICIAL SPREADING MELANOMA RADIAL GROWTH PHASE),n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 08:12:16,,1313771366,7/3/2014 08:11:21,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(the,n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 09:39:04,,1313844073,7/3/2014 09:38:03,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CONTRAINDICATES],[CONTRAINDICATES],significantly different,N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 14:22:00,,1313998257,7/3/2014 14:20:39,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",component of,N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 14:41:39,,1314011414,7/3/2014 14:41:32,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],than those,n/a,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505660,7/3/2014 15:17:00,,1314040733,7/3/2014 15:16:44,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(the RADIAL GROWTH PHASE),N/A,93,57,112,87,1,RO-disease_has_finding,901985,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA
497505661,7/3/2014 00:01:00,,1313497792,7/3/2014 00:00:46,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[LOCATION],[LOCATION],are more involved,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 00:07:29,,1313500922,7/3/2014 00:07:14,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],frontal lobe-BASAL,n/a,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 03:44:12,,1313625807,7/3/2014 03:43:13,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[TREATS],[TREATS],HUNTINGTON'S DISEASE lobe-BASAL GANGLIA STRUCTURES,n/a,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 03:44:49,,1313626132,7/3/2014 03:44:24,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 04:03:13,,1313636475,7/3/2014 04:02:27,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],HUNTINGTON'S DISEASE lobe-BASAL GANGLIA STRUCTURES,n/a,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 04:03:16,,1313636521,7/3/2014 04:02:14,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],HUNTINGTON'S DISEASE frontal lobe-BASAL GANGLIA STRUCTURES more involved HD,manifestation,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 04:53:37,,1313656607,7/3/2014 04:53:12,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],more involved,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 05:30:22,,1313677523,7/3/2014 05:29:57,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[CAUSES],[CAUSES],in,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 07:46:17,,1313743600,7/3/2014 07:46:05,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HUNTINGTON'S DISEASE lobe-BASAL GANGLIA STRUCTURES,n/a,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 08:34:02,,1313784449,7/3/2014 08:33:17,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],more involved HD,n/a,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 09:07:06,,1313817780,7/3/2014 09:06:32,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 09:37:29,,1313842980,7/3/2014 09:36:42,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[MANIFESTATION],[MANIFESTATION],more involved,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 14:31:21,,1314004575,7/3/2014 14:30:42,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],involved in HD,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 14:42:20,,1314011861,7/3/2014 14:42:10,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],patients HUNTINGTON'S,n/a,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505661,7/3/2014 15:01:16,,1314028825,7/3/2014 15:00:56,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[LOCATION],[LOCATION],frontal,N/A,101,42,125,62,1,RO-has_finding_site,905446,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE
497505662,7/3/2014 00:13:39,,1313504048,7/3/2014 00:13:26,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[IS_A],[IS_A],is,n/a,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 00:37:08,,1313514705,7/3/2014 00:36:56,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 02:25:54,,1313580470,7/3/2014 02:24:29,tremorgames,1.0,25257192,CAN,ON,North York,207.188.64.245,[OTHER],[OTHER],"obstructive lung diseases such as ASTHMA, CYSTIC FIBROSIS,",N/A,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 03:54:06,,1313631666,7/3/2014 03:53:48,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 04:04:30,,1313637141,7/3/2014 04:03:34,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[OTHER],[OTHER],feature of obstructive lung diseases such as,N/A,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 04:17:36,,1313642810,7/3/2014 04:17:00,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASTHMA, CYSTIC FIBROSIS,",n/a,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 05:01:50,,1313660931,7/3/2014 05:01:24,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASTHMA, CYSTIC FIBROSIS, bronchiectasis",n/a,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 05:12:32,,1313666394,7/3/2014 05:12:16,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],such as,N/A,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 08:39:03,,1313787572,7/3/2014 08:38:47,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 09:10:02,,1313821094,7/3/2014 09:09:45,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 09:47:56,,1313849836,7/3/2014 09:47:32,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[CONTRAINDICATES] [MANIFESTATION],"[MANIFESTATION]
[CONTRAINDICATES]","ASTHMA, CYSTIC FIBROSIS,",n/a,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 09:54:50,,1313854191,7/3/2014 09:54:18,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],diseases such as,N/A,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 14:32:44,,1314005499,7/3/2014 14:31:51,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[OTHER],[OTHER],obstructive lung diseases,Both lung diseases.,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 14:36:25,,1314007852,7/3/2014 14:36:17,instagc,1.0,27753923,GBR,"","",92.40.75.232,[TREATS],[TREATS],feature of obstructive,n/a,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505662,7/3/2014 15:15:29,,1314039570,7/3/2014 15:15:08,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,124,132,130,147,-1,RO-has_manifestation,906460,"Mucociliary dysfunction is an important feature of obstructive lung diseases such as chronic obstructive pulmonary disease, ASTHMA, CYSTIC FIBROSIS, and bronchiectasis",ASTHMA,CYSTIC FIBROSIS
497505663,7/3/2014 00:07:43,,1313501029,7/3/2014 00:07:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],consisting of,N/A,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 00:09:12,,1313501619,7/3/2014 00:08:52,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],and,n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 00:40:12,,1313515851,7/3/2014 00:40:03,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 03:38:03,,1313622166,7/3/2014 03:37:26,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MICROANGIOPATHIC HEMOLYTIC ANEMIA, RENAL DYSFUNCTION",n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 03:48:43,,1313628377,7/3/2014 03:48:29,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 04:07:01,,1313638199,7/3/2014 04:05:52,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],"uremic syndrome consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, RENAL DYSFUNCTION",manifestation,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 04:07:35,,1313638478,7/3/2014 04:07:03,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MICROANGIOPATHIC HEMOLYTIC ANEMIA, RENAL DYSFUNCTION",n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 05:15:50,,1313668426,7/3/2014 05:15:36,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 05:16:26,,1313668776,7/3/2014 05:15:09,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, and RENAL DYSFUNCTION",n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 07:31:33,,1313732337,7/3/2014 07:31:08,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MICROANGIOPATHIC HEMOLYTIC ANEMIA, and RENAL DYSFUNCTION",n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 08:27:36,,1313780442,7/3/2014 08:26:25,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 08:59:08,,1313808745,7/3/2014 08:58:27,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],n/a,both part of a syndrome but not directly related,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 09:43:02,,1313846537,7/3/2014 09:41:24,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],consisting of,N/A,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 14:43:33,,1314012671,7/3/2014 14:43:25,instagc,1.0,27753923,GBR,"","",92.40.75.232,[SYMPTOM],[SYMPTOM],uncommon clinical,n/a,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505663,7/3/2014 15:17:54,,1314041543,7/3/2014 15:17:45,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,142,85,159,118,-1,RO-has_manifestation,906259,"The hemolytic uremic syndrome in adults is an uncommon clinical entity consisting of MICROANGIOPATHIC HEMOLYTIC ANEMIA, thrombocytopenia, and RENAL DYSFUNCTION",RENAL DYSFUNCTION,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505664,7/3/2014 00:05:59,,1313500227,7/3/2014 00:05:47,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 00:16:12,,1313505241,7/3/2014 00:15:37,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",in LUPUS patients,N/A,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 00:47:15,,1313519521,7/3/2014 00:47:04,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM],[SYMPTOM],in,N/A,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 02:10:53,,1313572076,7/3/2014 02:10:17,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,NA,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 04:00:48,,1313635520,7/3/2014 03:59:48,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],presence of HAEMOLYTIC ANAEMIA in LUPUS patients,symptom,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 04:01:46,,1313635900,7/3/2014 04:01:14,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[LOCATION],[LOCATION],HAEMOLYTIC ANAEMIA LUPUS,n/a,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 04:05:34,,1313637599,7/3/2014 04:05:19,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,N/A,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 04:46:37,,1313653480,7/3/2014 04:46:12,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],presence of in,N/A,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 04:53:26,,1313656569,7/3/2014 04:51:26,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[SYMPTOM],[SYMPTOM],presence of HAEMOLYTIC ANAEMIA in,n/a,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 05:06:16,,1313663050,7/3/2014 05:05:52,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[LOCATION],[LOCATION],HAEMOLYTIC ANAEMIA LUPUS,n/a,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 05:18:00,,1313669754,7/3/2014 05:17:36,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SYMPTOM],[SYMPTOM],in,N/A,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 08:16:12,,1313773493,7/3/2014 08:14:57,prodege,1.0,21891314,AUS,07,Mornington,203.214.41.115,[MANIFESTATION],[MANIFESTATION],presence of HAEMOLYTIC ANAEMIA in LUPUS patients,N/A,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 09:09:02,,1313819973,7/3/2014 09:08:18,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[SYMPTOM],[SYMPTOM],in,na,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 10:43:34,,1313885598,7/3/2014 10:43:24,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HAEMOLYTIC ANAEMIA LUPUS,n/a,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505664,7/3/2014 14:41:30,,1314011310,7/3/2014 14:41:21,instagc,1.0,27753923,GBR,"","",92.40.75.232,[MANIFESTATION],[MANIFESTATION],HAEMOLYTIC ANAEMIA,n/a,16,38,34,43,-1,RO-has_manifestation,906260,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS
497505665,7/2/2014 23:59:38,,1313497042,7/2/2014 23:59:17,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SYMPTOM],[SYMPTOM],with,n/a,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 00:35:59,,1313514211,7/3/2014 00:35:49,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],admitted,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 01:05:16,,1313529610,7/3/2014 01:04:47,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[SYMPTOM],[SYMPTOM],cough FEVER,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 02:14:49,,1313574275,7/3/2014 02:12:41,zoombucks,1.0,27687111,USA,CA,Corona,99.44.120.153,[SYMPTOM],[SYMPTOM],admitted with FEVER,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 02:26:32,,1313580819,7/3/2014 02:25:56,tremorgames,1.0,25257192,CAN,ON,North York,207.188.64.245,[SYMPTOM],[SYMPTOM],HEPATOCELLULAR CARCINOMA (HCC) was admitted with FEVER,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 03:44:32,,1313625956,7/3/2014 03:43:57,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],HEPATOCELLULAR CARCINOMA FEVER,n/a,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 03:46:15,,1313626965,7/3/2014 03:45:07,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[SYMPTOM],[SYMPTOM],HEPATOCELLULAR CARCINOMA FEVER,n/a,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 03:52:06,,1313630513,7/3/2014 03:51:51,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],with,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 03:52:12,,1313630561,7/3/2014 03:51:19,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[OTHER]",admitted with cough and,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 05:26:30,,1313675335,7/3/2014 05:26:18,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SIDE_EFFECT],[SIDE_EFFECT],with,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 07:33:48,,1313733636,7/3/2014 07:33:36,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEPATOCELLULAR CARCINOMA FEVER,n/a,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 09:03:57,,1313814274,7/3/2014 09:03:29,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],admitted with,na,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 14:36:25,,1314007862,7/3/2014 14:36:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",with,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 14:38:18,,1314009056,7/3/2014 14:38:05,instagc,1.0,27753923,GBR,"","",92.40.75.232,[SYMPTOM],[SYMPTOM],HEPATOCELLULAR CARCINOMA,n/a,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505665,7/3/2014 15:03:47,,1314030807,7/3/2014 15:03:32,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],was admitted with,N/A,82,23,87,47,1,RO-disease_may_have_finding,902533,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA
497505666,7/2/2014 23:56:04,,1313495569,7/2/2014 23:55:46,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",diagnosis affects,n/a,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 00:10:25,,1313502337,7/3/2014 00:10:18,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],led,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 00:10:33,,1313502436,7/3/2014 00:08:46,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],localized,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 03:43:09,,1313625230,7/3/2014 03:42:32,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SPINAL CORD NEUROMYELITIS OPTICA,n/a,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 03:56:25,,1313633087,7/3/2014 03:55:18,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[LOCATION],[LOCATION],localized SPINAL CORD NEUROMYELITIS OPTICA,location,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 03:56:37,,1313633196,7/3/2014 03:54:37,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",localized only to eventual serological diagnosis,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 03:57:50,,1313633852,7/3/2014 03:56:19,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CAUSES],[CAUSES],SPINAL CORD NEUROMYELITIS OPTICA,n/a,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 04:05:49,,1313637687,7/3/2014 04:05:35,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],localized,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 04:49:46,,1313654839,7/3/2014 04:49:25,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],serological diagnosis,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 05:29:39,,1313677145,7/3/2014 05:29:20,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],diagnosis,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 08:37:54,,1313786748,7/3/2014 08:37:22,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],eventual serological diagnosis,n/a,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 09:12:50,,1313824571,7/3/2014 09:12:03,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[SYMPTOM],[SYMPTOM],eventual serological diagnosis,na,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 09:30:58,,1313838844,7/3/2014 09:29:56,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],affects the spinal cord,N/A,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 10:44:20,,1313886069,7/3/2014 10:43:49,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SPINAL CORD NEUROMYELITIS OPTICA,n/a,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505666,7/3/2014 14:40:26,,1314010518,7/3/2014 14:40:17,instagc,1,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],localized only,n/a,65,121,76,141,1,RO-has_finding_site,905148,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA
497505667,7/3/2014 00:00:33,,1313497521,7/3/2014 00:00:19,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 00:09:41,,1313501915,7/3/2014 00:09:14,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],compare and,n/a,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 01:23:53,,1313543093,7/3/2014 01:22:48,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 03:42:22,,1313624727,7/3/2014 03:41:17,instagc,1,23149109,USA,NC,Durham,75.189.206.205,[ASSOCIATED_WITH],[ASSOCIATED_WITH],TYPE 1 DIABETES MELLITUS and CELIAC DISEASE,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 03:47:52,,1313627933,7/3/2014 03:47:35,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 04:23:29,,1313644687,7/3/2014 04:22:44,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],TYPE 1 DIABETES MELLITUS CELIAC DISEASE,n/a,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 04:48:44,,1313654427,7/3/2014 04:47:56,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],TYPE 1 DIABETES MELLITUS mellitus CELIAC DISEASE,n/a,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 05:35:44,,1313680448,7/3/2014 05:34:42,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 07:50:26,,1313747516,7/3/2014 07:50:00,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[NONE],[NONE],n/a,different diseases,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 09:14:45,,1313826852,7/3/2014 09:14:18,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],nA,no direct relation in sentence,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 09:46:11,,1313848594,7/3/2014 09:45:53,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",TYPE DIABETES MELLITUS CELIAC DISEASE,n/a,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 09:53:41,,1313853505,7/3/2014 09:53:02,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Their aim was to compare,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 14:37:42,,1314008705,7/3/2014 14:37:33,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],prevalence of autoimmune,n/a,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 15:02:47,,1314029951,7/3/2014 15:02:31,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prevalence of,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505667,7/3/2014 16:15:06,,1314089444,7/3/2014 16:14:15,bitcoinget,1,25255063,GBR,V2,Glasgow,86.174.15.198,[OTHER],[OTHER],with and,N/A,92,164,116,178,-1,RO-has_manifestation,906316,Their aim was also to compare the prevalence of autoimmune thyroid disease in patients with TYPE 1 DIABETES MELLITUS and in those with type 1 diabetes mellitus and CELIAC DISEASE,TYPE 1 DIABETES MELLITUS,CELIAC DISEASE
497505668,7/3/2014 00:06:44,,1313500558,7/3/2014 00:06:25,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SYMPTOM],[SYMPTOM],presented,n/a,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 00:47:46,,1313519739,7/3/2014 00:47:37,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 00:58:24,,1313526086,7/3/2014 00:57:39,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],DIARRHOEA,N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 01:43:02,,1313555307,7/3/2014 01:42:12,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]","DIARRHOEA, two with CHRONIC DIARRHOEA",N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 03:49:05,,1313628570,7/3/2014 03:48:45,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 04:05:52,,1313637699,7/3/2014 04:03:59,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],"DIARRHOEA, CHRONIC DIARRHOEA",is a,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 04:12:49,,1313640892,7/3/2014 04:12:12,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"DIARRHOEA, CHRONIC DIARRHOEA",n/a,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 04:58:44,,1313659350,7/3/2014 04:58:17,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"DIARRHOEA, CHRONIC DIARRHOEA",n/a,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 05:01:47,,1313660898,7/3/2014 05:00:59,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"DIARRHOEA, CHRONIC DIARRHOEA",N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 05:27:31,,1313676029,7/3/2014 05:27:11,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[NONE],[NONE],N/A,Different patients.,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 08:59:28,,1313809168,7/3/2014 08:59:10,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],n/a,no direct relation,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 09:53:00,,1313853100,7/3/2014 09:52:31,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[SYMPTOM],[SYMPTOM],pain,N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 10:43:23,,1313885479,7/3/2014 10:43:10,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"DIARRHOEA, CHRONIC DIARRHOEA",n/a,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 14:35:12,,1314007024,7/3/2014 14:35:01,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],presented with pain,n/a,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505668,7/3/2014 15:02:15,,1314029517,7/3/2014 15:02:00,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIARRHOEA,N/A,38,58,47,75,-1,RO-has_definitional_manifestation,904932,"Four patients presented with pain and DIARRHOEA, two with CHRONIC DIARRHOEA and one with recurrent melena",DIARRHOEA,CHRONIC DIARRHOEA
497505669,7/3/2014 00:02:56,,1313498671,7/3/2014 00:02:43,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 00:37:28,,1313514822,7/3/2014 00:37:18,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,N/A,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 02:20:32,,1313577440,7/3/2014 02:18:04,tremorgames,1,25257192,CAN,ON,North York,207.188.64.245,[OTHER],[OTHER],"MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of HYPERTHERMIA",N/A,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 03:52:55,,1313630939,7/3/2014 03:52:31,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],in the absence,N/A,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 03:54:12,,1313631735,7/3/2014 03:53:32,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[LOCATION],[LOCATION],MUSCLE RIGIDITY MALIGNANT HYPERTHERMIA,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 04:38:01,,1313649640,7/3/2014 04:37:06,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MUSCLE RIGIDITY rhabdomyolysis MALIGNANT HYPERTHERMIA,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 05:25:38,,1313674741,7/3/2014 05:25:07,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SIDE_EFFECT],[SIDE_EFFECT],absence of,N/A,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 07:32:29,,1313732835,7/3/2014 07:31:53,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MUSCLE RIGIDITY MALIGNANT HYPERTHERMIA,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 07:52:58,,1313750353,7/3/2014 07:52:02,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],volatile agents may be associated with complications such as MUSCLE RIGIDITY even absence of MALIGNANT HYPERTHERMIA,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 08:18:32,,1313774947,7/3/2014 08:16:53,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[OTHER],[OTHER],absence,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 09:36:40,,1313842504,7/3/2014 09:36:09,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 14:27:46,,1314002120,7/3/2014 14:26:48,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[NONE],[NONE],N/A,No relationship.,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 14:43:44,,1314012838,7/3/2014 14:43:34,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],MUSCLE and,n/a,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 15:16:16,,1314040205,7/3/2014 15:15:58,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[CONTRAINDICATES],[CONTRAINDICATES],even in the absence,N/A,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505669,7/3/2014 16:19:58,,1314093639,7/3/2014 16:19:04,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[NONE],[NONE],n/a,one is a complication; the other is a condition that may or may not be absent,187,268,202,290,-1,RO-has_manifestation,906347,"We believe the presence of the myopathy warranted the use of a 'non-triggering' anaesthetic, as suxamethonium and volatile agents may be associated with significant complications such as MUSCLE RIGIDITY and rhabdomyolysis in myopathic patients, even in the absence of MALIGNANT HYPERTHERMIA",MUSCLE RIGIDITY,MALIGNANT HYPERTHERMIA
497505670,7/3/2014 00:12:20,,1313503456,7/3/2014 00:11:53,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SIDE_EFFECT],[SIDE_EFFECT],with,n/a,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 00:19:01,,1313506490,7/3/2014 00:18:36,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",with,N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 00:40:01,,1313515798,7/3/2014 00:39:54,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 03:50:46,,1313629557,7/3/2014 03:49:24,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],"INFECTIOUS MONONUCLEOSIS FEVER,",n/a,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 03:58:20,,1313634119,7/3/2014 03:58:09,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],with,N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 04:09:13,,1313639212,7/3/2014 04:08:20,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"INFECTIOUS MONONUCLEOSIS with FEVER,",associated with,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 04:44:42,,1313652601,7/3/2014 04:44:04,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[SYMPTOM],[SYMPTOM],"INFECTIOUS MONONUCLEOSIS FEVER,",n/a,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 04:48:24,,1313654235,7/3/2014 04:47:44,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 04:55:39,,1313657707,7/3/2014 04:54:14,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[SYMPTOM],[SYMPTOM],with,n/a,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 05:02:59,,1313661531,7/3/2014 05:02:06,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SIDE_EFFECT],[SIDE_EFFECT],with,N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 09:05:43,,1313816233,7/3/2014 09:05:11,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,na,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 09:26:57,,1313835994,7/3/2014 09:25:27,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[IS_A],[IS_A],resemble,N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 10:48:37,,1313888786,7/3/2014 10:47:55,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",with,n/a,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 14:37:52,,1314008834,7/3/2014 14:37:44,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CONTRAINDICATES],[CONTRAINDICATES],"MONONUCLEOSIS with FEVER,",n/a,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505670,7/3/2014 15:25:13,,1314047661,7/3/2014 15:25:01,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],"with FEVER,",N/A,70,40,75,64,1,RO-disease_has_finding,901960,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS
497505671,7/3/2014 00:00:42,,1313497602,7/3/2014 00:00:05,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],in,n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 00:01:35,,1313498029,7/3/2014 00:01:23,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[LOCATION],[LOCATION],in the,N/A,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 00:22:19,,1313508122,7/3/2014 00:21:51,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],in the,N/A,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 03:34:31,,1313620160,7/3/2014 03:33:50,eup_slw,1,18329415,USA,PA,Folcroft,64.121.230.236,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in the,n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 03:42:22,,1313624725,7/3/2014 03:41:46,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],in,N/A,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 03:44:23,,1313625891,7/3/2014 03:43:07,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[IS_A],[IS_A],"TEMPORAL LOBE EPILEPSY, TEMPORAL LOBE both",N/A,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 03:59:32,,1313634840,7/3/2014 03:58:59,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],"TEMPORAL LOBE EPILEPSY, TEMPORAL LOBE",n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 04:50:22,,1313655127,7/3/2014 04:49:01,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[LOCATION],[LOCATION],in the,n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 05:03:51,,1313661880,7/3/2014 05:03:15,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[LOCATION],[LOCATION],"TEMPORAL LOBE EPILEPSY, TEMPORAL",n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 05:17:35,,1313669512,7/3/2014 05:17:17,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],TEMPORAL LOBE,N/A,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 08:34:55,,1313784876,7/3/2014 08:34:04,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In may contribute,n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 09:02:31,,1313812691,7/3/2014 09:02:10,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 09:41:23,,1313845449,7/3/2014 09:40:50,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],may contribute,N/A,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 10:50:57,,1313890383,7/3/2014 10:50:46,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"TEMPORAL LOBE EPILEPSY, TEMPORAL LOBE",n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505671,7/3/2014 14:40:15,,1314010404,7/3/2014 14:40:06,instagc,1.0,27753923,GBR,"","",92.40.75.232,[MANIFESTATION],[MANIFESTATION],excitatory amino,n/a,82,3,95,25,1,RO-has_finding_site,905008,"In TEMPORAL LOBE EPILEPSY, excitatory amino acid receptors in the hippocampus and TEMPORAL LOBE may contribute to both increased excitability and vulnerability to excitotoxic damage",TEMPORAL LOBE,TEMPORAL LOBE EPILEPSY
497505672,7/2/2014 23:52:44,,1313493794,7/2/2014 23:51:50,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],and,n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 00:36:56,,1313514633,7/3/2014 00:36:44,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 03:58:55,,1313634455,7/3/2014 03:58:43,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 03:59:42,,1313634948,7/3/2014 03:58:22,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY,",N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 04:13:42,,1313641323,7/3/2014 04:12:51,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, MCPH1 (MICROCEPHALY,",n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 04:39:33,,1313650240,7/3/2014 04:38:49,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, MCPH1 (MICROCEPHALY,",n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 04:41:52,,1313651261,7/3/2014 04:41:37,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 05:17:15,,1313669263,7/3/2014 05:16:53,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 07:31:52,,1313732474,7/3/2014 07:31:35,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, MCPH1",n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 07:55:39,,1313753759,7/3/2014 07:53:49,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[NONE],[NONE],n/a,other disprders,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 08:14:20,,1313772484,7/3/2014 08:13:31,prodege,1,21891314,AUS,07,Mornington,203.214.41.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY,",N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 08:39:38,,1313788049,7/3/2014 08:39:24,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 09:52:29,,1313852759,7/3/2014 09:51:48,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],observed,N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 14:36:05,,1314007644,7/3/2014 14:35:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"characterized by microcephaly and growth delay, including",N/A,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505672,7/3/2014 14:38:03,,1314008901,7/3/2014 14:37:55,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],additional disorders characterized,n/a,189,150,201,176,-1,RO-has_manifestation,906374,"Impaired ATR signaling is also observed in cell lines from additional disorders characterized by microcephaly and growth delay, including non-ATR-SS, NIJMEGEN BREAKAGE SYNDROME, and MCPH1 (MICROCEPHALY, primary autosomal recessive, 1)-dependent primary microcephaly",MICROCEPHALY,NIJMEGEN BREAKAGE SYNDROME
497505673,7/2/2014 23:52:53,,1313493935,7/2/2014 23:52:46,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 00:02:09,,1313498334,7/3/2014 00:01:31,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",and,n/a,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 00:11:23,,1313502974,7/3/2014 00:10:34,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"neurobehavioral disorders, such as",N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 02:17:42,,1313575884,7/3/2014 02:15:50,zoombucks,1,27687111,USA,CA,Corona,99.44.120.153,[NONE],[NONE],N/A,They are both neurobehavioral disorders.,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 03:25:38,,1313614690,7/3/2014 03:24:57,superrewards,1.0,23067591,USA,VA,Earlysville,71.48.142.94,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",Na,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 03:49:24,,1313628776,7/3/2014 03:49:06,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 03:58:15,,1313634057,7/3/2014 03:57:37,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[OTHER],[OTHER],"disorders, such as and",N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 03:58:20,,1313634105,7/3/2014 03:57:54,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SUPRAVALVULAR AORTIC STENOSIS WILLIAMS SYNDROME,n/a,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 05:01:19,,1313660730,7/3/2014 05:00:52,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SUPRAVALVULAR AORTIC STENOSIS WILLIAMS SYNDROME,n/a,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 05:13:06,,1313666734,7/3/2014 05:12:46,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 08:14:56,,1313772803,7/3/2014 08:14:22,prodege,1.0,21891314,AUS,07,Mornington,203.214.41.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 08:23:40,,1313777983,7/3/2014 08:22:34,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 08:54:26,,1313802978,7/3/2014 08:53:42,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],NA,Both are examples but not really related directly,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 09:35:35,,1313841776,7/3/2014 09:34:48,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,N/A,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505673,7/3/2014 10:45:17,,1313886652,7/3/2014 10:45:05,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME,n/a,141,175,170,192,-1,RO-has_manifestation,906298,"The first disorders to involve mutations in the elastin gene itself are, surprisingly, cardiovascular and neurobehavioral disorders, such as SUPRAVALVULAR AORTIC STENOSIS and WILLIAMS SYNDROME",SUPRAVALVULAR AORTIC STENOSIS,WILLIAMS SYNDROME
497505674,7/3/2014 00:10:17,,1313502214,7/3/2014 00:10:09,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 00:13:24,,1313503900,7/3/2014 00:12:41,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SIDE_EFFECT],[SIDE_EFFECT],role assist,n/a,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 00:20:12,,1313507077,7/3/2014 00:19:03,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[OTHER],[OTHER],and,Both lung conditions.,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 03:33:27,,1313619373,7/3/2014 03:31:47,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[CAUSES],[CAUSES],"ASTHMA, CYSTIC FIBROSIS",n/a,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 03:37:22,,1313621744,7/3/2014 03:36:22,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[SYMPTOM],[SYMPTOM],"ASTHMA, evidence dysfunction CYSTIC FIBROSIS",N/A,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 04:02:50,,1313636295,7/3/2014 04:02:33,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[NONE],[NONE],N/A,different diseases,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 04:12:31,,1313640729,7/3/2014 04:11:02,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[OTHER],[OTHER],"the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue evidence of their dysfunction",N/A,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 04:15:20,,1313641951,7/3/2014 04:14:44,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],"ASTHMA, CYSTIC FIBROSIS",n/a,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 04:42:28,,1313651543,7/3/2014 04:41:55,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[OTHER],[OTHER],and,n/a,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 05:27:11,,1313675841,7/3/2014 05:26:51,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SYMPTOM],[SYMPTOM],in,N/A,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 07:53:27,,1313751000,7/3/2014 07:52:58,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[NONE],[NONE],n/a,different diseases,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 08:58:27,,1313807869,7/3/2014 08:57:52,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],n/a,same trement but two conditions not related,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 09:40:42,,1313845013,7/3/2014 09:38:43,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASTHMA, CYSTIC FIBROSIS",associated with,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 09:58:03,,1313856013,7/3/2014 09:57:38,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],We review the role,N/A,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505674,7/3/2014 10:42:55,,1313885166,7/3/2014 10:42:42,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",and,n/a,118,163,124,178,-1,RO-has_manifestation,906227,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS
497505675,7/2/2014 23:53:13,,1313494093,7/2/2014 23:53:04,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],result from,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/2/2014 23:58:46,,1313496762,7/2/2014 23:58:28,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analyzed,n/a,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 00:08:45,,1313501410,7/3/2014 00:07:43,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and result from,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 01:08:23,,1313531811,7/3/2014 01:07:32,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",result inherited,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 03:41:16,,1313624129,7/3/2014 03:40:06,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[SYMPTOM],[SYMPTOM],CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 03:55:27,,1313632481,7/3/2014 03:55:12,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 04:10:08,,1313639706,7/3/2014 04:09:31,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONGENITAL ADRENAL HYPOPLASIA HYPOGONADOTROPIC HYPOGONADISM,n/a,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 04:49:40,,1313654787,7/3/2014 04:48:48,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONGENITAL ADRENAL HYPOPLASIA HYPOGONADOTROPIC HYPOGONADISM,n/a,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 04:57:40,,1313658772,7/3/2014 04:57:26,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 05:00:42,,1313660414,7/3/2014 05:00:07,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[OTHER],[OTHER],result from not only inherited but also de novo mutation,N?A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 05:33:20,,1313679140,7/3/2014 05:33:05,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 09:04:45,,1313815094,7/3/2014 09:04:22,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 10:45:04,,1313886545,7/3/2014 10:44:50,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM,n/a,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 14:36:57,,1314008216,7/3/2014 14:36:48,instagc,1.0,27753923,GBR,"","",92.40.75.232,[TREATS],[TREATS],established that CONGENITAL,n/a,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505675,7/3/2014 15:14:34,,1314038891,7/3/2014 15:14:25,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,258,224,287,253,-1,RO-has_manifestation,906442,"We analyzed the DAX-1 genes of two unrelated Japanese patients with congenital adrenal hypoplasia and hypogonadotropic hypogonadism using PCR amplification of genomic DNA and complete exonic sequencing, and established that CONGENITAL ADRENAL HYPOPLASIA and HYPOGONADOTROPIC HYPOGONADISM result from not only inherited but also de novo mutation in the DAX-1 gene",HYPOGONADOTROPIC HYPOGONADISM,CONGENITAL ADRENAL HYPOPLASIA
497505676,7/2/2014 23:52:24,,1313493610,7/2/2014 23:52:15,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 00:03:39,,1313499125,7/3/2014 00:03:17,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],with,n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 00:15:35,,1313504913,7/3/2014 00:14:58,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],(MCARDLE'S DISEASE),N/A,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 03:37:21,,1313621735,7/3/2014 03:36:29,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 03:44:23,,1313625890,7/3/2014 03:44:05,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[PART_OF],[PART_OF],(MCARDLE'S DISEASE),N/A,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 03:51:15,,1313629885,7/3/2014 03:50:16,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),N/A,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 03:56:17,,1313632996,7/3/2014 03:55:31,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 03:57:38,,1313633762,7/3/2014 03:56:27,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),it is,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 05:26:17,,1313675179,7/3/2014 05:25:38,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],MYOPHOSPHORYLASE DEFICIENCY,N/A,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 07:32:44,,1313732961,7/3/2014 07:32:31,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 07:52:00,,1313749342,7/3/2014 07:51:41,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[IS_A],[IS_A],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 08:06:58,,1313768051,7/3/2014 08:06:12,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[IS_A],[IS_A],(MCARDLE'S DISEASE),n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 09:00:47,,1313810726,7/3/2014 08:59:29,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE),n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 09:36:07,,1313842139,7/3/2014 09:35:37,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[TREATS],[TREATS],improve,N/A,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505676,7/3/2014 14:38:41,,1314009404,7/3/2014 14:38:34,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],reported to,n/a,108,79,125,106,-1,RO-has_manifestation,906064,Glucagon has been reported to improve exercise tolerance in some patients with MYOPHOSPHORYLASE DEFICIENCY (MCARDLE'S DISEASE) but a placebo effect was not excluded in previous trials,MCARDLE'S DISEASE,MYOPHOSPHORYLASE DEFICIENCY
497505677,7/3/2014 00:05:29,,1313499950,7/3/2014 00:05:02,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],is,n/a,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 00:12:10,,1313503370,7/3/2014 00:11:57,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],originates,N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 00:16:32,,1313505394,7/3/2014 00:16:13,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],(IPF),N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 03:43:07,,1313625208,7/3/2014 03:42:22,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[IS_A],[IS_A],IDIOPATHIC PULMONARY FIBROSIS (IPF),N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 03:59:40,,1313634934,7/3/2014 03:58:56,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[IS_A],[IS_A],(IPF),N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 04:19:11,,1313643301,7/3/2014 04:18:19,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Hypothesis IDIOPATHIC PULMONARY FIBROSIS (IPF),n/a,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 04:51:03,,1313655452,7/3/2014 04:49:46,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[CAUSES],[CAUSES],Hypothesis Origination Idiopathic Pulmonary Fibrosis IDIOPATHIC PULMONARY FIBROSIS epithelium,n/a,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 05:15:35,,1313668269,7/3/2014 05:15:04,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],IDIOPATHIC PULMONARY FIBROSIS,N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 07:35:46,,1313735054,7/3/2014 07:34:23,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IDIOPATHIC PULMONARY FIBROSIS,n/a,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 08:52:40,,1313800926,7/3/2014 08:51:54,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],N/A,they are the same thing,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 09:38:01,,1313843373,7/3/2014 09:37:05,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],IDIOPATHIC PULMONARY FIBROSIS (IPF),is a,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 09:56:49,,1313855354,7/3/2014 09:56:10,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[SYMPTOM],[SYMPTOM],repeated episodes,N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 14:43:06,,1314012442,7/3/2014 14:42:58,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Pulmonary Fibrosis,n/a,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 15:17:14,,1314040933,7/3/2014 15:17:01,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(IPF),N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505677,7/3/2014 16:12:53,,1314087715,7/3/2014 16:12:11,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[OTHER],[OTHER],Idiopathic Pulmonary Fibrosis is (IPF),N/A,122,91,125,120,-1,RO-has_manifestation,906137,"Hypothesis for Origination of Idiopathic Pulmonary Fibrosis The current hypothesis is that IDIOPATHIC PULMONARY FIBROSIS (IPF) originates with repeated episodes of injury to the epithelium that result in formation of a microscopic lesion?in essence, a wound?in the wall of the alveolus ( a",IPF,IDIOPATHIC PULMONARY FIBROSIS
497505678,7/3/2014 00:03:16,,1313498845,7/3/2014 00:02:58,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is a associated,n/a,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 00:38:47,,1313515285,7/3/2014 00:38:38,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 04:04:56,,1313637279,7/3/2014 04:04:39,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 04:07:00,,1313638195,7/3/2014 04:06:23,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"HYPERARGININAEMIA, OROTIC ACIDURIA,",n/a,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 04:48:45,,1313654421,7/3/2014 04:48:26,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 05:02:49,,1313661465,7/3/2014 05:01:25,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]","HYPERARGININAEMIA, OROTIC ACIDURIA,",symptom and/or manifestation,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 05:05:11,,1313662542,7/3/2014 05:04:43,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"HYPERARGININAEMIA, OROTIC ACIDURIA,",n/a,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 05:12:46,,1313666556,7/3/2014 05:12:32,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 08:07:31,,1313768569,7/3/2014 08:06:59,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 09:08:15,,1313819081,7/3/2014 09:08:01,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 09:25:25,,1313835053,7/3/2014 09:24:41,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 09:46:35,,1313848899,7/3/2014 09:46:12,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"HYPERARGININAEMIA, OROTIC ACIDURIA,",n/a,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 14:28:25,,1314002522,7/3/2014 14:27:48,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by and,N/A,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 14:38:51,,1314009496,7/3/2014 14:38:43,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],associated with,n/a,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505678,7/3/2014 15:13:27,,1314038020,7/3/2014 15:13:17,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,163,118,178,135,-1,RO-has_manifestation,906125,"Arginase deficiency is a rare, autosomal recessive, disorder of the urea cycle characterized by mild hyperammonaemia, HYPERARGININAEMIA, dibasic aminoaciduria and OROTIC ACIDURIA, associated with progressive spastic tetraplegia, seizures, psychomotor retardation, and growth failure",OROTIC ACIDURIA,HYPERARGININAEMIA
497505679,7/3/2014 00:00:03,,1313497282,7/2/2014 23:59:40,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],compared,n/a,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 00:37:45,,1313514928,7/3/2014 00:37:29,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],compared,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 03:56:57,,1313633374,7/3/2014 03:56:34,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],compared,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 04:12:10,,1313640600,7/3/2014 04:11:24,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]","Alzheimer type (DAT) HUNTINGTON'S DISEASE (HD), DEMENTIA,",n/a,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 04:43:17,,1313651959,7/3/2014 04:42:40,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Alzheimer type (DAT) HUNTINGTON'S DISEASE (HD),",n/a,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 04:55:39,,1313657706,7/3/2014 04:55:10,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",with,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 05:15:03,,1313667961,7/3/2014 05:14:29,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SIDE_EFFECT],[SIDE_EFFECT],matched,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 07:34:22,,1313734005,7/3/2014 07:34:06,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]","HUNTINGTON'S DISEASE DEMENTIA,",n/a,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 07:44:25,,1313742322,7/3/2014 07:43:26,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],"HUNTINGTON'S DISEASE overall level DEMENTIA,",manifestation,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 08:20:49,,1313776335,7/3/2014 08:18:34,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],matched overall level of,n/a,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 09:07:38,,1313818413,7/3/2014 09:07:07,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],matched for overall level,na,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 09:28:05,,1313836798,7/3/2014 09:26:59,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],matched,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 14:29:10,,1314003011,7/3/2014 14:28:49,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",matched for overall level of,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 14:37:32,,1314008618,7/3/2014 14:37:22,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],study compared the,n/a,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505679,7/3/2014 15:13:16,,1314037902,7/3/2014 15:12:58,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],overall level,N/A,195,130,203,150,-1,RO-has_manifestation,906278,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE
497505680,7/2/2014 23:52:13,,1313493504,7/2/2014 23:52:05,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/2/2014 23:55:06,,1313495065,7/2/2014 23:54:48,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[LOCATION],[LOCATION],presence,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 03:48:15,,1313628162,7/3/2014 03:47:37,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[LOCATION],[LOCATION],ASTHMA CYSTIC FIBROSIS ABPA,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 03:59:47,,1313634981,7/3/2014 03:58:36,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presence ASTHMA or CYSTIC FIBROSIS recognition,associated with,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 04:04:23,,1313637098,7/3/2014 04:04:06,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 04:14:56,,1313641779,7/3/2014 04:13:58,tremorgames,1.0,25257192,CAN,ON,North York,207.188.64.245,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA,N/A,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 04:41:09,,1313650854,7/3/2014 04:40:45,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 04:55:10,,1313657461,7/3/2014 04:54:37,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ASTHMA CYSTIC FIBROSIS ABPA,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 05:32:44,,1313678772,7/3/2014 05:32:24,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],the presence of,N/A,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 08:35:18,,1313785091,7/3/2014 08:34:56,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 08:56:26,,1313805305,7/3/2014 08:55:57,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],n/a,not related,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 09:47:19,,1313849408,7/3/2014 09:47:10,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ASTHMA or CYSTIC FIBROSIS,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 10:00:05,,1313857173,7/3/2014 09:58:34,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[MANIFESTATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",require recognition,N/A,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 14:22:23,,1313998551,7/3/2014 14:22:01,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],for recognition of,N/A,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505680,7/3/2014 14:42:28,,1314011943,7/3/2014 14:42:21,instagc,1.0,27753923,GBR,"","",92.40.75.232,[SYMPTOM],[SYMPTOM],require the,n/a,57,67,63,82,-1,RO-has_manifestation,906052,"Also, current criteria generally require the presence of ASTHMA or CYSTIC FIBROSIS for recognition of ABPA",ASTHMA,CYSTIC FIBROSIS
497505681,7/3/2014 00:08:04,,1313501128,7/3/2014 00:07:31,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 00:10:59,,1313502740,7/3/2014 00:10:48,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 01:10:32,,1313533549,7/3/2014 01:08:25,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",data figures,N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 02:15:48,,1313574839,7/3/2014 02:14:50,zoombucks,1.0,27687111,USA,CA,Corona,99.44.120.153,[ASSOCIATED_WITH],[ASSOCIATED_WITH],risk figures for,N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 02:23:11,,1313578802,7/3/2014 02:21:48,tremorgames,1.0,25257192,CAN,ON,North York,207.188.64.245,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]","estimating relative risk figures for GLAUCOMA, in children with STURGE-WEBER SYNDROME",N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 03:40:53,,1313623915,7/3/2014 03:40:08,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[LOCATION],[LOCATION],"GLAUCOMA, STURGE-WEBER SYNDROME",n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 03:46:52,,1313627340,7/3/2014 03:46:30,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[MANIFESTATION],[MANIFESTATION],with,N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 04:06:20,,1313637947,7/3/2014 04:05:34,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],"GLAUCOMA, STURGE-WEBER SYNDROME",n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 04:10:21,,1313639791,7/3/2014 04:09:14,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"seizures, GLAUCOMA, with STURGE-WEBER SYNDROME",associated with,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 04:57:25,,1313658616,7/3/2014 04:57:06,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 05:29:57,,1313677314,7/3/2014 05:29:40,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SIDE_EFFECT],[SIDE_EFFECT],with,N/A,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 07:27:34,,1313731071,7/3/2014 07:26:49,prodege,1,14848125,GBR,V2,Glasgow,86.130.194.252,[MANIFESTATION],[MANIFESTATION],"seizures, GLAUCOMA, and mental retardation",n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 08:28:07,,1313780783,7/3/2014 08:27:39,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],with,n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 08:57:15,,1313806369,7/3/2014 08:56:26,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[ASSOCIATED_WITH],[ASSOCIATED_WITH],relative risk,n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505681,7/3/2014 09:47:09,,1313849291,7/3/2014 09:46:57,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"GLAUCOMA, STURGE-WEBER SYNDROME",n/a,96,146,104,167,-1,RO-has_manifestation,906189,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME
497505682,7/3/2014 00:00:18,,1313497399,7/3/2014 00:00:02,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[TREATS],[TREATS],improve recovery,N/A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 00:11:41,,1313503158,7/3/2014 00:11:25,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",improve recovery,n/a,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 00:17:49,,1313505980,7/3/2014 00:17:12,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],SPINAL CORD,N/A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 03:52:31,,1313630748,7/3/2014 03:52:07,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],after,N/A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 04:11:21,,1313640255,7/3/2014 04:10:48,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[TREATS],[TREATS],SPINAL CORD SPINAL CORD INJURY (SCI);,n/a,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 04:47:50,,1313653989,7/3/2014 04:46:37,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PREVENTS],[PREVENTS],SPINAL CORD SPINAL CORD INJURY,n/a,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 05:00:58,,1313660525,7/3/2014 05:00:43,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[LOCATION],[LOCATION],SPINAL CORD,N?A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 05:14:27,,1313667608,7/3/2014 05:13:56,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],SPINAL CORD,N/A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 09:02:09,,1313812273,7/3/2014 09:00:48,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 09:32:39,,1313839965,7/3/2014 09:31:57,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[TREATS],[TREATS],benefit,N/A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 10:42:40,,1313885026,7/3/2014 10:42:23,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SPINAL CORD and SPINAL CORD INJURY,n/a,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 14:43:15,,1314012506,7/3/2014 14:43:08,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],induces molecular,n/a,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 15:01:56,,1314029315,7/3/2014 15:01:37,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[LOCATION],[LOCATION],SPINAL CORD,N/A,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 16:24:46,,1314097960,7/3/2014 16:23:38,clixsense,1,6621167,USA,"","",66.87.76.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,Na,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505682,7/3/2014 16:26:06,,1314099163,7/3/2014 16:25:15,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[TREATS],[TREATS],can improve recovery,n/a,91,134,102,152,1,RO-has_finding_site,905460,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY
497505683,7/3/2014 00:13:30,,1313503956,7/3/2014 00:13:02,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 00:17:38,,1313505883,7/3/2014 00:17:10,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",defective infection,n/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 00:38:57,,1313515363,7/3/2014 00:38:48,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 03:58:35,,1313634228,7/3/2014 03:57:40,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed,manifestation,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 04:02:10,,1313636053,7/3/2014 04:00:09,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 04:16:55,,1313642565,7/3/2014 04:16:12,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AQUEDUCTAL STENOSIS HYDROCEPHALUS,n/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 04:57:35,,1313658716,7/3/2014 04:57:04,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AQUEDUCTAL STENOSIS HYDROCEPHALUS,n/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 05:05:04,,1313662501,7/3/2014 05:04:22,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 07:40:07,,1313738439,7/3/2014 07:39:57,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AQUEDUCTAL STENOSIS HYDROCEPHALUS,n/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 09:34:45,,1313841366,7/3/2014 09:34:00,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],developed,N/A,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 14:40:04,,1314010310,7/3/2014 14:39:57,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],animals sequela,n/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 15:14:57,,1314039184,7/3/2014 15:14:47,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 16:09:55,,1314085354,7/3/2014 16:09:10,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[NONE],[NONE],n/a,two different developments,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 16:31:35,,1314103883,7/3/2014 16:31:15,neodev,1.0,18517457,GBR,"","",86.29.55.201,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505683,7/3/2014 17:12:57,,1314135715,7/3/2014 17:11:53,prodege,1.0,14848125,GBR,V2,Glasgow,86.130.194.252,[ASSOCIATED_WITH],[ASSOCIATED_WITH],STENOSIS and HYDROCEPHALUS developed,n/a,164,140,177,159,-1,RO-has_manifestation,906467,"Similar lesions followed defective infection with influenza A in both hamsters and mice; when a large amount of influenza A was inoculated, AQUEDUCTAL STENOSIS and HYDROCEPHALUS developed in some adult animals as a sequela of widespread ependymal cell loss",HYDROCEPHALUS,AQUEDUCTAL STENOSIS
497505684,7/3/2014 00:12:39,,1313503627,7/3/2014 00:12:21,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",and,n/a,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 00:47:56,,1313519877,7/3/2014 00:47:47,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and a,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 03:26:45,,1313615347,7/3/2014 03:25:39,superrewards,1.0,23067591,USA,VA,Earlysville,71.48.142.94,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In analysis of an OSTEOSARCOMA and RETINOBLASTOMA,Na,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 03:34:08,,1313619833,7/3/2014 03:32:57,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[SYMPTOM],[SYMPTOM],OSTEOSARCOMA and RETINOBLASTOMA,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 04:06:08,,1313637851,7/3/2014 04:05:51,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 04:12:36,,1313640772,7/3/2014 04:11:16,neodev,1.0,20929875,USA,MA,Boston,71.174.181.181,[ASSOCIATED_WITH],[ASSOCIATED_WITH],analysis of an OSTEOSARCOMA and a RETINOBLASTOMA,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 04:21:52,,1313644194,7/3/2014 04:21:11,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],OSTEOSARCOMA RETINOBLASTOMA,n/a,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 04:50:09,,1313655048,7/3/2014 04:49:47,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 04:53:48,,1313656718,7/3/2014 04:52:52,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],OSTEOSARCOMA RETINOBLASTOMA,n/a,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 05:11:26,,1313665809,7/3/2014 05:09:59,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[OTHER],[OTHER],and a,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 05:24:54,,1313674294,7/3/2014 05:24:41,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 07:43:19,,1313741330,7/3/2014 07:43:06,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and a,n/a,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 09:14:15,,1313826343,7/3/2014 09:13:28,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no dierct relation in sentence,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 09:41:58,,1313845818,7/3/2014 09:40:43,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[LOCATION],[LOCATION],OSTEOSARCOMA RETINOBLASTOMA endpoints deletions within the confines,location,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505684,7/3/2014 09:50:44,,1313851617,7/3/2014 09:49:58,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]",discovered,N/A,22,41,34,55,-1,RO-has_manifestation,906146,In the analysis of an OSTEOSARCOMA and a RETINOBLASTOMA we discovered that the endpoints of the deletions were within the confines of the genetic unit defined by the probe,OSTEOSARCOMA,RETINOBLASTOMA
497505685,7/3/2014 00:14:14,,1313504302,7/3/2014 00:13:40,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES] [LOCATION],"[CAUSES]
[LOCATION]",discovered,n/a,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 00:46:18,,1313518954,7/3/2014 00:46:07,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],for,im not 100% sure,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 01:25:02,,1313543798,7/3/2014 01:23:55,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[NONE],[NONE],N/A,Two different things.,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 01:41:15,,1313554144,7/3/2014 01:40:27,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",discovered during evaluation,N/A,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 03:45:57,,1313626768,7/3/2014 03:44:34,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],GAMMA HEAVY CHAIN DISEASE SPLENOMEGALY,n/a,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 03:49:47,,1313629000,7/3/2014 03:49:25,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],during,N/A,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 04:46:32,,1313653447,7/3/2014 04:45:48,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],GAMMA HEAVY CHAIN DISEASE pancytopenia SPLENOMEGALY,n/a,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 05:03:48,,1313661856,7/3/2014 05:02:51,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],GAMMA HEAVY CHAIN DISEASE was discovered SPLENOMEGALY,diagnosed by test or drug,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 05:28:06,,1313676326,7/3/2014 05:27:51,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],discovered,N/A,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 07:41:51,,1313740013,7/3/2014 07:41:39,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GAMMA HEAVY CHAIN DISEASE SPLENOMEGALY,n/a,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 07:58:00,,1313756405,7/3/2014 07:56:36,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[MANIFESTATION],[MANIFESTATION],was discovered during evaluation for,n/a,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 09:17:02,,1313828885,7/3/2014 09:16:39,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],evaluation for,na,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 10:00:46,,1313857746,7/3/2014 10:00:06,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],was discovered during evaluation,N/A,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 14:36:01,,1314007605,7/3/2014 14:35:51,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],HEAVY CHAIN DISEASE,n/a,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505685,7/3/2014 15:23:40,,1314046318,7/3/2014 15:23:24,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],discovered during evaluation,N/A,116,15,128,40,1,RO-disease_may_have_finding,902622,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE
497505686,7/3/2014 00:01:21,,1313497934,7/3/2014 00:01:12,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],defined by,N/A,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 00:02:42,,1313498596,7/3/2014 00:02:29,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[IS_A],[IS_A],is a,n/a,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 00:05:31,,1313499965,7/3/2014 00:05:03,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],defined by,N/A,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 03:31:55,,1313618350,7/3/2014 03:31:12,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[SYMPTOM],[SYMPTOM],"MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER,",N/A,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 03:47:17,,1313627659,7/3/2014 03:46:20,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER,",n/a,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 04:02:12,,1313636095,7/3/2014 04:00:49,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION] [TREATS],"[TREATS]
[MANIFESTATION]","defined MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER,",manifestation,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 04:02:32,,1313636217,7/3/2014 04:02:12,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 04:21:02,,1313643885,7/3/2014 04:19:53,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER,",n/a,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 05:12:13,,1313666211,7/3/2014 05:11:27,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],defined by,n/a,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 05:34:41,,1313679839,7/3/2014 05:33:45,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[SYMPTOM],[SYMPTOM],syndrome defined by,N/A,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 07:43:36,,1313741671,7/3/2014 07:43:20,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]","MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER,",n/a,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 09:11:29,,1313822848,7/3/2014 09:11:06,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 09:48:00,,1313849859,7/3/2014 09:46:27,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],clinical syndrome,N/A,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 14:42:09,,1314011739,7/3/2014 14:41:52,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],purpura abnormalities,n/a,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505686,7/3/2014 15:24:44,,1314047275,7/3/2014 15:24:33,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,137,102,142,135,-1,RO-has_manifestation,906060,"Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, MICROANGIOPATHIC HEMOLYTIC ANEMIA, FEVER, and renal and neurologic abnormalities",FEVER,MICROANGIOPATHIC HEMOLYTIC ANEMIA
497505687,7/2/2014 23:57:48,,1313496319,7/2/2014 23:57:28,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",suffered,n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 00:11:31,,1313503038,7/3/2014 00:11:16,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM],[SYMPTOM],criteria,N/A,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 03:47:34,,1313627789,7/3/2014 03:47:17,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],diagnostic criteria,N/A,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 04:22:40,,1313644482,7/3/2014 04:21:58,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],"HEADACHE, MIGRAINE",n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 04:41:35,,1313651101,7/3/2014 04:41:11,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[MANIFESTATION],[MANIFESTATION],fulfilled diagnostic criteria,n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 04:58:11,,1313659097,7/3/2014 04:57:40,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"HEADACHE, MIGRAINE",n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 04:58:43,,1313659346,7/3/2014 04:55:40,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],diagnostic criteria,n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 05:23:24,,1313673183,7/3/2014 05:22:25,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[IS_A],[IS_A],of,N/A,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 07:39:51,,1313738229,7/3/2014 07:39:09,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],"50% suffered HEADACHE, 32.8% diagnostic criteria MIGRAINE",is a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 07:42:15,,1313740357,7/3/2014 07:41:52,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"HEADACHE, MIGRAINE",n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 08:39:22,,1313787814,7/3/2014 08:39:04,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[SYMPTOM],[SYMPTOM],diagnostic criteria,n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 09:12:02,,1313823578,7/3/2014 09:11:30,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no dierct relation in sentence,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 09:49:57,,1313851101,7/3/2014 09:49:26,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],studied,N/A,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 14:30:41,,1314004142,7/3/2014 14:30:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],fulfilled the diagnostic criteria of,N/A,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505687,7/3/2014 14:40:38,,1314010689,7/3/2014 14:40:28,instagc,1.0,27753923,GBR,"","",92.40.75.232,[MANIFESTATION],[MANIFESTATION],50% suffered,n/a,51,108,59,116,-1,RO-has_definitional_manifestation,904961,"In the group of patients studied 50% suffered from HEADACHE, and 32.8% fulfilled the diagnostic criteria of MIGRAINE",HEADACHE,MIGRAINE
497505688,7/3/2014 00:10:48,,1313502591,7/3/2014 00:09:43,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],found,n/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 00:11:56,,1313503274,7/3/2014 00:11:45,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 02:10:15,,1313571613,7/3/2014 02:09:05,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[NONE],[NONE],microgaming casino list the best microgaming casinos in one,History does not occur in list.,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 03:53:32,,1313631339,7/3/2014 03:53:14,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 04:08:06,,1313638751,7/3/2014 04:07:37,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],ATOPIC DERMATITIS ALLERGIC RHINITIS,n/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 04:38:43,,1313649915,7/3/2014 04:38:06,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[LOCATION],[LOCATION],ATOPIC DERMATITIS ALLERGIC RHINITIS,n/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 05:23:40,,1313673410,7/3/2014 05:23:24,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[PART_OF],[PART_OF],and,N/A,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 07:33:35,,1313733506,7/3/2014 07:33:23,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ATOPIC DERMATITIS ALLERGIC RHINITIS,n/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 14:33:45,,1314006212,7/3/2014 14:32:45,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[NONE],[NONE],N/A,No clear relationship from the sentence.,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 14:36:35,,1314007970,7/3/2014 14:36:27,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"in 21.3%, allergic",n/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 15:03:31,,1314030553,7/3/2014 15:03:18,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,lst,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 16:21:16,,1314094633,7/3/2014 16:19:59,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[NONE],[NONE],n/a,different conditions are listed,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 16:32:54,,1314104945,7/3/2014 16:32:24,neodev,1.0,18517457,GBR,"","",86.29.55.201,[OTHER],[OTHER],and,N/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 17:13:27,,1314136182,7/3/2014 17:12:58,prodege,1.0,14848125,GBR,V2,Glasgow,86.130.194.252,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"history found in 21.3%,",n/a,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505688,7/3/2014 17:16:08,,1314138481,7/3/2014 17:14:34,prodege,1,9378607,GBR,U8,Edinburgh,94.1.221.80,[NONE],[NONE],n/a,They are completely separate medical conditions only related as they are in a study of adolescents,79,13,96,30,-1,RO-has_manifestation,906162,"A history of ATOPIC DERMATITIS was found in 21.3%, allergic asthma in 6.9% and ALLERGIC RHINITIS in 15.7% of the adolescents",ALLERGIC RHINITIS,ATOPIC DERMATITIS
497505689,7/2/2014 23:54:03,,1313494561,7/2/2014 23:53:42,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 00:11:15,,1313502896,7/3/2014 00:11:00,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[MANIFESTATION],[MANIFESTATION],and,N/A,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 03:48:28,,1313628251,7/3/2014 03:48:09,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 04:14:41,,1313641715,7/3/2014 04:13:47,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ESSENTIAL THROMBOCYTHEMIA, THROMBOCYTOSIS",n/a,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 04:46:56,,1313653635,7/3/2014 04:46:39,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 05:04:38,,1313662337,7/3/2014 05:03:56,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ESSENTIAL THROMBOCYTHEMIA, THROMBOCYTOSIS",n/a,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 05:27:50,,1313676197,7/3/2014 05:27:31,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 07:37:29,,1313736260,7/3/2014 07:36:21,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PART_OF],[PART_OF],"ESSENTIAL THROMBOCYTHEMIA, THROMBOCYTOSIS",a part of,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 09:03:28,,1313813723,7/3/2014 09:02:31,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 09:33:58,,1313840815,7/3/2014 09:32:40,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[SYMPTOM],[SYMPTOM],is present,N/A,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 10:43:08,,1313885313,7/3/2014 10:42:55,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ESSENTIAL THROMBOCYTHEMIA, THROMBOCYTOSIS",n/a,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 14:26:46,,1314001488,7/3/2014 14:25:49,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],present in virtually all patients with,N/A,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 14:36:15,,1314007783,7/3/2014 14:36:03,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],"years, was discovered",n/a,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 15:03:02,,1314030126,7/3/2014 15:02:48,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505689,7/3/2014 16:28:30,,1314101345,7/3/2014 16:26:06,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[NONE],[NONE],n/a,different conditions are listed,278,179,292,204,-1,RO-has_manifestation,906081,"During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with ESSENTIAL THROMBOCYTHEMIA, primary myelofibrosis, and refractory anemia with ring sideroblasts and THROMBOCYTOSIS",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA
497505690,7/2/2014 23:57:26,,1313496156,7/2/2014 23:56:05,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PREVENTS],[PREVENTS],preventing,n/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 00:38:37,,1313515200,7/3/2014 00:37:58,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(HANE),N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 01:01:09,,1313527659,7/3/2014 01:00:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[IS_A],[IS_A],(HANE),N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 03:43:39,,1313625511,7/3/2014 03:43:11,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[PART_OF],[PART_OF],(HANE),N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 04:01:11,,1313635715,7/3/2014 04:00:20,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PREVENTS],[PREVENTS],"(DEA), HEREDITARY ANGIONEUROTIC EDEMA (HANE)",n/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 04:59:25,,1313659764,7/3/2014 04:58:49,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PREVENTS],[PREVENTS],"(DEA), HEREDITARY ANGIONEUROTIC EDEMA (HANE)",n/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 05:04:22,,1313662148,7/3/2014 05:03:00,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],HEREDITARY ANGIONEUROTIC EDEMA,N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 07:42:51,,1313740838,7/3/2014 07:42:16,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]","(DEA), HEREDITARY ANGIONEUROTIC EDEMA (HANE)",n/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 09:55:26,,1313854607,7/3/2014 09:54:51,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[PREVENTS],[PREVENTS],preventing,N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 14:42:47,,1314012124,7/3/2014 14:42:39,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"(DEA), an",n/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 15:16:43,,1314040499,7/3/2014 15:16:19,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(HANE),N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 16:09:09,,1314084688,7/3/2014 16:08:29,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[TREATS],[TREATS],successfully used for preventing,n/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 16:13:30,,1314088257,7/3/2014 16:13:09,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[PREVENTS],[PREVENTS],successfully used for preventing attacks,N/A,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 16:34:42,,1314106479,7/3/2014 16:34:00,neodev,1.0,18517457,GBR,"","",86.29.55.201,[IS_A],[IS_A],HEREDITARY ANGIONEUROTIC EDEMA (HANE),N/a,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505690,7/3/2014 17:14:32,,1314137078,7/3/2014 17:13:30,prodege,1.0,9378607,GBR,U8,Edinburgh,94.1.221.80,[OTHER],[OTHER],HEREDITARY ANGIONEUROTIC EDEMA (HANE),It is an abbreviation,108,140,138,144,-1,RO-has_manifestation,906033,"The effect of dehydroepiandrosterone (DEA), an adrenal androgen successfully used for preventing attacks in HEREDITARY ANGIONEUROTIC EDEMA (HANE) patients was studied on the activation of classical and alternative complement pathway",HEREDITARY ANGIONEUROTIC EDEMA,HANE
497505691,7/2/2014 23:59:43,,1313497060,7/2/2014 23:59:34,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 00:04:20,,1313499490,7/3/2014 00:03:41,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],and,n/a,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 03:53:47,,1313631498,7/3/2014 03:53:34,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 04:09:26,,1313639326,7/3/2014 04:08:49,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"BRONCHIAL ASTHMA, ATOPIC DERMATITIS,",n/a,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 04:52:46,,1313656257,7/3/2014 04:52:07,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"BRONCHIAL ASTHMA, ATOPIC DERMATITIS,",n/a,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 05:13:25,,1313666919,7/3/2014 05:12:16,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],program toward,n/a,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 05:31:58,,1313678350,7/3/2014 05:31:33,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[PART_OF],[PART_OF],and,N/A,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 07:39:03,,1313737516,7/3/2014 07:37:31,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],N/A,"They were in a test group, but don't appear to be related",93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 09:16:39,,1313828569,7/3/2014 09:16:16,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no direct relation in sentence,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 09:46:25,,1313848807,7/3/2014 09:45:23,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"family group,",N/A,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 09:47:31,,1313849567,7/3/2014 09:47:21,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"BRONCHIAL ASTHMA, ATOPIC DERMATITIS,",n/a,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 14:23:22,,1313999187,7/3/2014 14:22:25,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],allergic prevention program,N/A,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 14:39:24,,1314009797,7/3/2014 14:39:03,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],from previous investigations,n/a,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 15:15:08,,1314039311,7/3/2014 15:14:58,fepcrowdflower,1,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,list,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505691,7/3/2014 16:10:28,,1314085743,7/3/2014 16:09:56,instagc,1,18531561,CAN,ON,Mississauga,99.229.185.45,[NONE],[NONE],n/a,different conditions listed,93,134,109,151,-1,RO-has_manifestation,906310,"The setup of the first allergic prevention program improved attitudes and perceptions toward BRONCHIAL ASTHMA, allergic rhinitis, and ATOPIC DERMATITIS, by the education of the risk family group, based on the results from previous investigations and adapted to the procedures and customs that govern our current society",BRONCHIAL ASTHMA,ATOPIC DERMATITIS
497505692,7/3/2014 00:00:44,,1313497629,7/3/2014 00:00:34,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[IS_A],[IS_A],from,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 00:01:30,,1313497986,7/3/2014 00:00:43,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],misdiagnosed,n/a,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 00:07:22,,1313500849,7/3/2014 00:06:30,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM],[SYMPTOM],when it presents with,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 03:36:16,,1313621112,7/3/2014 03:35:12,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CONTRAINDICATES],[CONTRAINDICATES],"SEIZURES, EPILEPSY",n/a,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 04:05:17,,1313637457,7/3/2014 04:04:57,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[SYMPTOM],[SYMPTOM],with,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 04:56:16,,1313658019,7/3/2014 04:55:40,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],differentiate from,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 05:06:27,,1313663140,7/3/2014 05:05:30,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[CAUSES],[CAUSES],presents with,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 05:07:35,,1313663681,7/3/2014 05:07:00,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[CONTRAINDICATES],[CONTRAINDICATES],"SEIZURES, LQTS EPILEPSY",n/a,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 07:39:14,,1313737698,7/3/2014 07:39:01,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]","SEIZURES, EPILEPSY",n/a,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 08:14:22,,1313772522,7/3/2014 08:13:09,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[CONTRAINDICATES],[CONTRAINDICATES],differentiate from,n/a,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 09:06:31,,1313817130,7/3/2014 09:06:13,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 09:44:35,,1313847569,7/3/2014 09:43:04,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],at risk of sudden death,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 14:33:36,,1314006117,7/3/2014 14:33:06,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],misdiagnosed epilepsy risk sudden death,n/a,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 15:12:57,,1314037634,7/3/2014 15:12:39,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[SYMPTOM],[SYMPTOM],presents with,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505692,7/3/2014 16:11:48,,1314086878,7/3/2014 16:11:11,bitcoinget,1.0,25255063,GBR,V2,Glasgow,86.174.15.198,[SYMPTOM],[SYMPTOM],when it presents with,N/A,80,133,88,141,-1,RO-has_definitional_manifestation,904952,"Although LQTS can be potentially misdiagnosed as epilepsy when it presents with SEIZURES, it is important to differentiate LQTS from EPILEPSY because patients with LQTS are at risk of sudden death",SEIZURES,EPILEPSY
497505693,7/2/2014 23:53:03,,1313494016,7/2/2014 23:52:54,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"panbronchiolitis,",N/A,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 00:17:07,,1313505681,7/3/2014 00:16:34,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,N/A,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 00:17:09,,1313505685,7/3/2014 00:16:51,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SIDE_EFFECT],[SIDE_EFFECT],respond,n/a,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 03:39:56,,1313623281,7/3/2014 03:39:09,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASTHMA, CYSTIC FIBROSIS,",n/a,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 03:41:45,,1313624429,7/3/2014 03:40:59,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[NONE],[NONE],N/A,different diseases,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 04:25:23,,1313645359,7/3/2014 04:24:17,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASTHMA, panbronchiolitis, CYSTIC FIBROSIS,",n/a,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 04:50:25,,1313655153,7/3/2014 04:50:11,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 05:00:05,,1313660070,7/3/2014 04:59:24,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[OTHER],[OTHER],Lung diseases such as,N?A,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 05:00:23,,1313660247,7/3/2014 04:58:47,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Lung diseases such as ASTHMA, CYSTIC FIBROSIS,",associated with,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 05:12:14,,1313666232,7/3/2014 05:10:56,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[OTHER],[OTHER],such as,N/A,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 07:40:51,,1313739090,7/3/2014 07:40:35,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]","ASTHMA, CYSTIC FIBROSIS,",n/a,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 08:24:53,,1313778728,7/3/2014 08:23:42,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such and,n/a,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 09:10:40,,1313821933,7/3/2014 09:10:26,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 09:48:31,,1313850192,7/3/2014 09:48:02,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[TREATS],[TREATS],respond,N/A,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505693,7/3/2014 14:37:21,,1314008458,7/3/2014 14:37:10,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],"CYSTIC FIBROSIS,",n/a,22,48,28,63,-1,RO-has_manifestation,906056,"Lung diseases such as ASTHMA, panbronchiolitis, CYSTIC FIBROSIS, and bronchiectasis are thought to respond to the immunomodulatory properties of macrolides",ASTHMA,CYSTIC FIBROSIS
497505694,7/3/2014 00:00:01,,1313497223,7/2/2014 23:59:44,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[CAUSES],[CAUSES],may enhance the development,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 00:07:13,,1313500744,7/3/2014 00:06:46,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],enhance,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 01:07:29,,1313531141,7/3/2014 01:06:20,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],induces enhance development,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 01:22:46,,1313542338,7/3/2014 01:22:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",may enhance the development of,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 03:38:28,,1313622405,7/3/2014 03:37:23,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[SIDE_EFFECT],[SIDE_EFFECT],ATOPIC DERMATITIS may enhance the development of ASTHMA,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 03:44:04,,1313625749,7/3/2014 03:43:41,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[CAUSES],[CAUSES],enhance,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 04:03:57,,1313636890,7/3/2014 04:03:15,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CAUSES],[CAUSES],ATOPIC DERMATITIS ASTHMA,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 04:43:58,,1313652252,7/3/2014 04:43:22,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[CAUSES],[CAUSES],ATOPIC DERMATITIS ASTHMA,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 05:29:19,,1313676934,7/3/2014 05:28:50,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[MANIFESTATION],[MANIFESTATION],development,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 08:38:44,,1313787336,7/3/2014 08:37:56,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[CAUSES],[CAUSES],may enhance development,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 10:47:37,,1313888098,7/3/2014 10:46:49,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ATOPIC DERMATITIS ASTHMA,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 14:36:46,,1314008112,7/3/2014 14:36:37,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],mice to a protein,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 15:24:59,,1314047440,7/3/2014 15:24:45,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[CAUSES],[CAUSES],enhance the development,N/A,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 16:23:50,,1314097038,7/3/2014 16:21:17,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[CAUSES],[CAUSES],may enhance the development of,n/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505694,7/3/2014 16:33:18,,1314105308,7/3/2014 16:32:55,neodev,1,18517457,GBR,"","",86.29.55.201,[CAUSES],[CAUSES],may enhance the development of,N/a,255,206,261,223,-1,RO-has_manifestation,906135,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS
497505695,7/2/2014 23:55:44,,1313495386,7/2/2014 23:55:08,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[SIDE_EFFECT],[SIDE_EFFECT],contribute,n/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 00:01:10,,1313497862,7/3/2014 00:01:01,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 03:39:11,,1313622823,7/3/2014 03:38:29,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[CAUSES],[CAUSES],"lung diseases such as ASTHMA and CYSTIC FIBROSIS,",N/A,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 03:48:09,,1313628083,7/3/2014 03:47:53,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 04:00:18,,1313635248,7/3/2014 03:59:36,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[CAUSES],[CAUSES],"MUC5AC ASTHMA CYSTIC FIBROSIS,",n/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 05:03:10,,1313661589,7/3/2014 05:02:30,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[LOCATION],[LOCATION],"MUC5AC ASTHMA CYSTIC FIBROSIS,",n/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 05:07:54,,1313663874,7/3/2014 05:07:31,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 07:51:03,,1313748263,7/3/2014 07:50:27,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[OTHER],[OTHER],"mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS,",n/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 09:24:40,,1313834503,7/3/2014 09:23:40,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],chronic lung diseases such as,N/A,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 10:44:36,,1313886250,7/3/2014 10:44:21,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[MANIFESTATION],[MANIFESTATION],"ASTHMA and CYSTIC FIBROSIS,",n/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 14:23:50,,1313999579,7/3/2014 14:23:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[ASSOCIATED_WITH],[ASSOCIATED_WITH],chronic lung diseases such as,N/A,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 14:41:51,,1314011515,7/3/2014 14:41:41,instagc,1.0,27753923,GBR,"","",92.40.75.232,[PREVENTS],[PREVENTS],the reactive,n/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 15:14:24,,1314038767,7/3/2014 15:14:13,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[NONE],[NONE],N/A,separate,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 16:31:57,,1314104189,7/3/2014 16:31:36,neodev,1.0,18517457,GBR,"","",86.29.55.201,[MANIFESTATION],[MANIFESTATION],chronic lung diseases such as,N/a,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505695,7/3/2014 19:26:16,,1314249783,7/3/2014 19:24:13,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ASTHMA CYSTIC FIBROSIS,",associated with,163,174,169,189,-1,RO-has_manifestation,906266,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS
497505696,7/3/2014 00:05:45,,1313500108,7/3/2014 00:05:31,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 00:39:33,,1313515613,7/3/2014 00:39:24,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 03:30:31,,1313617565,7/3/2014 03:29:41,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[ASSOCIATED_WITH],[ASSOCIATED_WITH],KALLMANN SYNDROME ANOSMIA,n/a,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 03:35:03,,1313620333,7/3/2014 03:34:10,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[MANIFESTATION],[MANIFESTATION],features KALLMANN SYNDROME with ANOSMIA,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 03:38:13,,1313622264,7/3/2014 03:37:06,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],KALLMANN SYNDROME ANOSMIA,n/a,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 03:42:45,,1313624991,7/3/2014 03:42:23,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 04:03:28,,1313636650,7/3/2014 04:01:14,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[IS_A],[IS_A],features of with,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 04:03:57,,1313636901,7/3/2014 04:03:18,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],KALLMANN SYNDROME with ANOSMIA,associated with,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 05:31:32,,1313678135,7/3/2014 05:30:23,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 07:40:19,,1313738647,7/3/2014 07:40:08,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",KALLMANN SYNDROME ANOSMIA,n/a,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 09:13:27,,1313825373,7/3/2014 09:12:50,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,na,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 09:56:08,,1313854948,7/3/2014 09:55:28,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],were observed,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 14:31:51,,1314004914,7/3/2014 14:31:21,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",with,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 14:39:01,,1314009599,7/3/2014 14:38:53,instagc,1.0,27753923,GBR,"","",92.40.75.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ANOSMIA and hypogonadotropic,n/a,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505696,7/3/2014 15:24:18,,1314046938,7/3/2014 15:24:09,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,49,26,56,43,-1,RO-has_definitional_manifestation,905000,The classical features of KALLMANN SYNDROME with ANOSMIA and hypogonadotropic hypogonadism were observed in two sisters aged 13 and 19,ANOSMIA,KALLMANN SYNDROME
497505697,7/2/2014 23:51:28,,1313493161,7/2/2014 23:50:43,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[SYMPTOM],[SYMPTOM],progress,N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 00:11:23,,1313502984,7/3/2014 00:11:05,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[CAUSES],[CAUSES],part progress,n/a,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 00:14:16,,1313504336,7/3/2014 00:13:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],"changes to may, thus, explain",N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 01:46:10,,1313557281,7/3/2014 01:45:00,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[LOCATION] [PART_OF],"[LOCATION]
[PART_OF]",changes to the,N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 03:58:57,,1313634477,7/3/2014 03:58:21,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],PANCREAS PANCREATITIS,n/a,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 04:03:25,,1313636629,7/3/2014 04:03:11,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],in,N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 04:51:25,,1313655639,7/3/2014 04:50:24,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[CAUSES],[CAUSES],histological changes to the PANCREAS,n/a,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 05:08:51,,1313664391,7/3/2014 05:08:18,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[PART_OF],[PART_OF],PANCREAS PANCREATITIS,n/a,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 05:24:15,,1313673782,7/3/2014 05:23:54,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],of,N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 07:42:35,,1313740652,7/3/2014 07:41:38,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],changes to the PANCREAS part explain progress PANCREATITIS,associated with,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 08:13:29,,1313771985,7/3/2014 08:11:50,prodege,1.0,21891314,AUS,07,Mornington,203.214.41.115,[SYMPTOM],[SYMPTOM],changes to the PANCREAS explain the progress of PANCREATITIS,N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 08:53:41,,1313802116,7/3/2014 08:52:41,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],n/A,no relationship with PANCREAS alone,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 09:38:01,,1313843383,7/3/2014 09:37:32,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],progress,N/A,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 10:44:50,,1313886364,7/3/2014 10:44:37,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PANCREAS PANCREATITIS,n/a,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505697,7/3/2014 14:40:47,,1314010788,7/3/2014 14:40:39,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],vascularity correlated,n/a,98,154,106,166,1,RO-has_finding_site,905240,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS
497505698,7/3/2014 00:14:57,,1313504619,7/3/2014 00:14:18,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",may clinically mimick,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 00:18:08,,1313506082,7/3/2014 00:17:39,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF],[PART_OF],mimick,n/a,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 00:46:42,,1313519145,7/3/2014 00:46:30,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],these,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 02:24:28,,1313579593,7/3/2014 02:23:12,tremorgames,1.0,25257192,CAN,ON,North York,207.188.64.245,[ASSOCIATED_WITH],[ASSOCIATED_WITH],these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 03:46:17,,1313626982,7/3/2014 03:45:03,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"When accompanied by an ELEVATED PLATELET COUNT, mimick ESSENTIAL THROMBOCYTHEMIA",N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 03:53:30,,1313631308,7/3/2014 03:51:15,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[PART_OF],[PART_OF],"ELEVATED PLATELET COUNT, ESSENTIAL THROMBOCYTHEMIA",n/a,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 03:57:39,,1313633779,7/3/2014 03:56:59,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 04:51:15,,1313655544,7/3/2014 04:50:47,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by an mimick,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 05:00:15,,1313660165,7/3/2014 04:59:31,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"ELEVATED PLATELET COUNT, ESSENTIAL THROMBOCYTHEMIA",n/a,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 05:28:35,,1313676589,7/3/2014 05:28:07,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[MANIFESTATION],[MANIFESTATION],mimick,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 09:10:24,,1313821566,7/3/2014 09:10:02,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[OTHER],[OTHER],clinically mimick,na,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 09:51:47,,1313852302,7/3/2014 09:50:45,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],mimick,N/A,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 10:50:31,,1313890061,7/3/2014 10:49:09,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ELEVATED PLATELET COUNT, ESSENTIAL THROMBOCYTHEMIA",n/a,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 11:16:36,,1313914509,7/3/2014 11:15:28,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ELEVATED PLATELET COUNT, clinically mimick ESSENTIAL THROMBOCYTHEMIA",associated with,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505698,7/3/2014 14:43:24,,1314012566,7/3/2014 14:43:17,instagc,1.0,27753923,GBR,"","",92.40.75.232,[CAUSES],[CAUSES],"ELEVATED PLATELET COUNT,",n/a,23,93,46,118,1,RO-disease_has_finding,901991,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA
497505699,7/3/2014 00:16:33,,1313505375,7/3/2014 00:16:24,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,n/a,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 00:36:12,,1313514337,7/3/2014 00:36:01,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 03:45:03,,1313626292,7/3/2014 03:44:23,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN),",N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 03:51:49,,1313630333,7/3/2014 03:51:33,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 03:53:35,,1313631370,7/3/2014 03:52:22,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.161,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and peripheral neuropathy,N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 04:11:15,,1313640222,7/3/2014 04:10:14,neodev,1,20929875,USA,MA,Boston,71.174.181.181,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MSS syndrome defined FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN),",N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 04:26:10,,1313645547,7/3/2014 04:25:32,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[SYMPTOM],[SYMPTOM],"MSS FACIAL DYSMORPHISM (CCFDN),",n/a,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 04:41:50,,1313651235,7/3/2014 04:40:45,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[SYMPTOM],[SYMPTOM],"MSS FACIAL DYSMORPHISM peripheral neuropathy (CCFDN),",n/a,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 04:46:11,,1313653280,7/3/2014 04:45:54,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 05:33:44,,1313679317,7/3/2014 05:33:22,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],defined by,N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 07:43:24,,1313741413,7/3/2014 07:42:36,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[LOCATION],[LOCATION],"FACIAL DYSMORPHISM (CCFDN), localised to 18qter",location,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 07:49:59,,1313747043,7/3/2014 07:49:27,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"defined by FACIAL DYSMORPHISM and (CCFDN),",n/a,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 09:05:10,,1313815619,7/3/2014 09:04:46,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[NONE],[NONE],na,no relation in sentence,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 09:21:20,,1313832234,7/3/2014 09:19:51,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is localised,N/A,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505699,7/3/2014 10:49:08,,1313889102,7/3/2014 10:48:39,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"FACIAL DYSMORPHISM (CCFDN),",n/a,89,135,107,140,-1,RO-has_manifestation,906414,"The major differential diagnosis of MSS is the syndrome defined by congenital cataracts, FACIAL DYSMORPHISM and peripheral neuropathy (CCFDN), which is localised to 18qter",FACIAL DYSMORPHISM,CCFDN
497505700,7/3/2014 00:05:00,,1313499751,7/3/2014 00:04:46,prodege,1.0,7061586,AUS,02,Toongabbie,114.76.177.0,[PART_OF] [CAUSES],"[CAUSES]
[PART_OF]",of the caused,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 00:13:00,,1313503736,7/3/2014 00:12:41,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,[LOCATION],[LOCATION],of the,N/A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 00:36:29,,1313514418,7/3/2014 00:36:13,neodev,1.0,21241714,CAN,ON,Kitchener,216.58.1.155,[LOCATION],[LOCATION],the,N/A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 01:03:39,,1313528872,7/3/2014 01:03:08,clixsense,1.0,10428985,GBR,M3,South Petherton,86.186.150.111,[CAUSES],[CAUSES],caused by a carcinoma of the colon,N/A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 03:50:31,,1313629450,7/3/2014 03:50:07,zoombucks,1.0,5919735,USA,PA,Lansdale,96.245.83.248,[LOCATION],[LOCATION],of,N/A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 04:10:44,,1313639975,7/3/2014 04:10:10,rewardsspot,1.0,17763704,USA,VA,Manassas,198.7.62.204,[LOCATION],[LOCATION],HEPATIC METASTASIS LIVER,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 04:54:32,,1313657096,7/3/2014 04:53:54,rewardsspot,1.0,24482174,GBR,H9,London,46.23.68.180,[LOCATION],[LOCATION],HEPATIC METASTASIS LIVER,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 05:09:58,,1313664994,7/3/2014 05:06:58,neodev,1.0,18755947,GBR,H2,Accrington,80.47.187.155,[LOCATION],[LOCATION],of the,N?A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 05:25:06,,1313674414,7/3/2014 05:24:54,tremorgames,1.0,19721342,CAN,ON,Ottawa,99.246.56.98,[LOCATION],[LOCATION],of the,N/A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 08:26:24,,1313779664,7/3/2014 08:24:56,prodege,1.0,15439740,AUS,02,Jannali,27.96.208.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of the,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 08:55:56,,1313804705,7/3/2014 08:55:08,prodege,1.0,18240009,GBR,H9,London,159.92.106.183,[PART_OF],[PART_OF],of the,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 10:46:48,,1313887647,7/3/2014 10:46:30,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",HEPATIC METASTASIS LIVER,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 14:42:38,,1314012034,7/3/2014 14:42:29,instagc,1.0,27753923,GBR,"","",92.40.75.232,[LOCATION],[LOCATION],underwent resection,n/a,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 15:02:29,,1314029733,7/3/2014 15:02:15,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,[LOCATION],[LOCATION],of the,N/A,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
497505700,7/3/2014 16:16:30,,1314090538,7/3/2014 16:14:59,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,[OTHER],[OTHER],of the,it is a disease of the liver,74,48,79,66,1,RO-has_finding_site,905138,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS
